<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Biol Chem</journal-id><journal-id journal-id-type="pmc-domain-id">567</journal-id><journal-id journal-id-type="pmc-domain">jbc</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12774752</article-id><article-id pub-id-type="pmcid-ver">PMC12774752.1</article-id><article-id pub-id-type="pmcaid">12774752</article-id><article-id pub-id-type="pmcaiid">12774752</article-id><article-id pub-id-type="pmid">41308988</article-id><article-id pub-id-type="doi">10.1016/j.jbc.2025.110976</article-id><article-id pub-id-type="pii">S0021-9258(25)02828-5</article-id><article-id pub-id-type="publisher-id">110976</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>4E-BP1 differentially regulates translation of a subset of human mRNAs</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Mahbub</surname><given-names initials="M">Mehreen</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Saha</surname><given-names initials="B">Baishakhi</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Goss</surname><given-names initials="DJ">Dixie J.</given-names></name><email>dgoss@hunter.cuny.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><aff id="aff1"><label>1</label>Department of Chemistry, Hunter College, City University of New York, New York, USA</aff><aff id="aff2"><label>2</label>PhD. Program in Biochemistry, The Graduate Center of the City University of New York, New York, USA</aff><aff id="aff3"><label>3</label>PhD. Program in Chemistry, The Graduate Center of the City University of New York, New York, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>For correspondence: Dixie J. Goss <email>dgoss@hunter.cuny.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>1</month><year>2026</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>2025</year></pub-date><volume>302</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">502987</issue-id><elocation-id>110976</elocation-id><history><date date-type="received"><day>27</day><month>10</month><year>2025</year></date><date date-type="rev-recd"><day>16</day><month>11</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>11</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>08</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-01-08 15:25:13.993"><day>08</day><month>01</month><year>2026</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><p>Elevated levels of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) influence cap-independent translation by forming a complex with eukaryotic initiation factor 4E (eIF4E) (eIF4E&#8226;4E-BP1). Certain mRNAs&#8212;including those encoding hypoxia-inducible factor-1&#945; (HIF-1&#945;), fibroblast growth factor-9 (FGF-9), and two isoforms of tumor suppressors, p53 (p53<sub>A</sub>, and p53<sub>B</sub>)&#8212;contain structured 5&#8242;untranslated regions (UTRs) that enable translation either <italic toggle="yes">via</italic> cap-independent translation enhancer (CITE)-like or internal ribosomal entry site (IRES)-like mechanisms. However, how 4E-BP1 modulates these mechanisms remains unclear. Using fluorescence-based anisotropy assays, we showed that the eIF4E&#8226;4E-BP1 binds more tightly to the 5&#8242; m<sup>7</sup>G-cap of these mRNAs than eIF4E alone. Luciferase reporter assays further demonstrated that 4E-BP1 inhibits translation of CITE-like (HIF-1&#945;, and p53<sub>A</sub>) more effectively than IRES-like (FGF-9, and p53<sub>B</sub>) mRNAs. Although binding affinity of eIF4E&#8226;4E-BP1 to each of these mRNAs increased, only CITE-like mRNA translation was significantly inhibited. Importantly, eIF4GI<sub>557-1599</sub> and its binding partner eIF4A, overcomes this inhibition selectively for CITE-like mRNAs, while eIF4E alone has only partial effects. In contrast, IRES-like mRNAs, despite binding to eIF4E&#8226;4E-BP1, exhibited only a modest translational repression and were minimally affected by eIF4GI<sub>557-1599</sub>&#8226;eIF4A or eIF4E. These findings reveal that 4E-BP1 selectively represses cap-independent translation in a transcript-specific manner. Moreover, fluorescence anisotropy revealed that 4E-BP1 enhances eIF4GI<sub>557-1599</sub> recruitment to certain mRNAs, potentially facilitating 43S pre-initiation complex (43S PIC) assembly during stress. These results provide new mechanistic insights into selective translational control with implications for stress response and cancer progression <italic toggle="yes">via</italic> non-canonical translation.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>cap-independent translation initiation</kwd><kwd>5&#8242; cap-independent translation enhancer (CITE)</kwd><kwd>internal ribosome entry site (IRES)</kwd><kwd>eIF4GI<sub>557-1599</sub></kwd><kwd>eIF4E</kwd><kwd>4E-BP1</kwd><kwd>eIF4A</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><def-list><title>Abbreviations</title><def-item><term id="kwrd0050">4E-BP1</term><def><p>eukaryotic initiation factor 4E-binding protein 1</p></def></def-item><def-item><term id="kwrd0060">eIF</term><def><p>eukaryotic initiation factor</p></def></def-item><def-item><term id="kwrd0070">eIF4A</term><def><p>eukaryotic initiation factor 4A</p></def></def-item><def-item><term id="kwrd0080">eIF4E</term><def><p>eukaryotic initiation factor 4E</p></def></def-item><def-item><term id="kwrd0090">eIF4GI</term><def><p>eukaryotic initiation factor 4 gamma I</p></def></def-item><def-item><term id="kwrd0100">FGF-9</term><def><p>fibroblast growth factor 9</p></def></def-item><def-item><term id="kwrd0110">FLuc</term><def><p>firefly luciferase</p></def></def-item><def-item><term id="kwrd0120">HIF-1&#945;</term><def><p>hypoxia-inducible factor 1 subunit alpha</p></def></def-item><def-item><term id="kwrd0130">K<sub>D</sub></term><def><p>equilibrium dissociation constant</p></def></def-item><def-item><term id="kwrd0140">Luc</term><def><p>luciferase</p></def></def-item><def-item><term id="kwrd0150">m<sup>7</sup>G</term><def><p>7-methylguanosine</p></def></def-item><def-item><term id="kwrd0160">p53<sub>A</sub> and p53<sub>B</sub></term><def><p>isoforms of tumor suppressor p53</p></def></def-item><def-item><term id="kwrd0170">PIC</term><def><p>Pre-initiation complex</p></def></def-item><def-item><term id="kwrd0180">RRL</term><def><p>rabbit reticulocyte lysate</p></def></def-item><def-item><term id="kwrd0190">UTR</term><def><p>untranslated region</p></def></def-item></def-list><notes><p id="misc0010">Reviewed by members of the JBC Editorial Board. Edited by Ronald Wek</p></notes></front><body><p id="p0010">Protein translation initiation is a complex and highly orchestrated process essential for maintaining cellular homeostasis and is a critical target in cancer development and tumor progression. This translation regulation involves the recruitment of translational machinery to mRNAs, through specific structural features, most notably the m<sup>7</sup>G-cap at the 5&#8242; end of the mRNA and is vital to cellular physiology. Its disruption contributes to disease (<xref rid="bib1" ref-type="bibr">1</xref>). Under basal cellular conditions, eukaryotic initiation factor 4E (eIF4E) availability governs cap-dependent translation initiation and serves as a rate-limiting step (<xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref>). Its availability is tightly regulated by eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), a stable (<xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>) downstream effector of mechanistic target of rapamycin (mTOR) activity (<xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>) that binds eIF4E to form a inhibitory complex (hereafter referred to as eIF4E&#8226;4E-BP1), blocking translation initiation until 4E-BP1 is phosphorylated. A fundamental distinction in translation mechanisms lies between cap-dependent and eIF4E-independent translation initiation, the latter allowing cells to bypass reliance on eIF4E when cap-dependent translation is impaired. eIF4E-independent translation is particularly important under stress conditions such as tumor hypoxia, viral infection, DNA damage, and nutrient deprivation (<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>). In these contexts, certain mRNAs, including those encoding stress response proteins, exploit these non-canonical mechanisms to recruit the ribosome independent of eIF4E recognition of the m<sup>7</sup>G-cap.</p><p id="p0015">During cap-dependent translation initiation, 4E-BP1 undergoes hyperphosphorylation by the kinases of the mTOR pathway. Hyperphosphorylated 4E-BP1, with critical phosphorylation sites at Thr37/Thr46, Ser65, and Thr70 (<xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib15" ref-type="bibr">15</xref>), dissociates from eIF4E. This dissociation is often facilitated by polyubiquitination, which reduces the affinity of 4E-BP1 for eIF4E (<xref rid="bib4" ref-type="bibr">4</xref>). The release of eIF4E from the eIF4E&#8226;4E-BP1 allows eIF4E to bind to the 5&#8242; cap of mRNAs and recruit other eIFs to form the eukaryotic initiation factor 4F (eIF4F) complex near the 5&#8242;cap to initiate translation. The eIF4F complex, comprising of eIF4E (cap-binding subunit), eIF4A (mRNA helicase), and eIF4GI (scaffolding protein) (<xref rid="bib16" ref-type="bibr">16</xref>), then facilitates the assembly of the 43S Pre-initiation complex (PIC) onto the 5&#8242;cap of mRNA and the machinery starts to move toward the start codon (AUG) to initiate translation (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>). However, under unfavorable cellular conditions, mTOR inhibition leads to hypo-phosphorylation and subsequent activation of 4E-BP1 (<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>). This process, likely mediated by protein phosphatase 2A (<xref rid="bib22" ref-type="bibr">22</xref>), enables 4E-BP1 to bind to eIF4E, inhibiting translation of most mRNAs. However, certain mRNAs can bypass 4E-BP1 inhibition and utilize non-canonical translation, collectively termed as eIF4E-independent translation. While it is commonly assumed that 4E-BP1 sequesters eIF4E to inhibit this translation, we show that this is not the case, and the mechanism is more complex. This alternative mechanism of translation initiation relies on structured elements within the 5&#8217; untranslated regions (5&#8242;UTRs), bypassing the requirement for the cap-binding protein, eIF4E (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>).</p><p id="p0020">During stress conditions, eIF4E-independent translation allows cells to reprogram their translation process to preserve cellular homeostasis by maintaining formation of key regulatory proteins. A key regulator of this process is 4E-BP1, which is overexpressed in &#8764;40% of cancers (<xref rid="bib25" ref-type="bibr">25</xref>), including breast (<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>), gastrointestinal, esophageal, and lung adenocarcinoma cancers (<xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>). Its overexpression is often associated with aggressive tumor behavior and poor patient prognosis (<xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>). Elevated 4E-BP1 levels shift the translational landscape, selectively promoting the eIF4E-independent translation of mRNAs <italic toggle="yes">via</italic> highly stable structures within the 5&#8242;UTRs of specific mRNAs. Two such mechanisms are Internal Ribosome Entry Sites (IRES)-like and Cap-Independent Translation Enhancers (CITE)-like mechanisms, allowing translation to proceed independently of the 5&#8242; cap (<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib35" ref-type="bibr">35</xref>). IRES-like mechanisms require minimal initiation factors and translation is initiated through direct recruitment of the 43S PIC at or near the AUG (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib37" ref-type="bibr">37</xref>), bypassing the need for the 5' cap (<xref rid="bib38" ref-type="bibr">38</xref>). On the other hand, CITE-like mechanisms require a free 5&#8242; end to recruit initiation factors and initiate translation <italic toggle="yes">via</italic> 43S PIC scanning (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib38" ref-type="bibr">38</xref>). These structured elements within the 5&#8242;UTRs enable selective translation of specific mRNAs even under conditions where cap-dependent initiation is suppressed, a strategy also exploited by various plant mRNA viruses (<xref rid="bib39" ref-type="bibr">39</xref>). While these mechanisms are functionally defined, the precise secondary structures or sequence motifs within these 5&#8242; UTRs have not been well studied. Examples of mRNAs that utilize these mechanisms include fibroblast growth factor-9 (FGF-9), hypoxia-inducible factor-1&#945; (HIF-1&#945;), and two isoforms of p53 (p53<sub>A</sub>, and p53<sub>B</sub>) (<xref rid="bib34" ref-type="bibr">34</xref>), all of which are translationally upregulated under hypoxic conditions, where cap-dependent translation is inhibited (<xref rid="bib34" ref-type="bibr">34</xref>), and 4E-BP1 is overexpressed (<xref rid="bib25" ref-type="bibr">25</xref>). These mRNAs were chosen because they represent functionally relevant transcripts that bypass cap-dependent translation inhibition under stress. FGF-9, and p53<sub>B</sub> encoding mRNAs seem to use an IRES-like mechanism of translation initiation (<xref rid="bib38" ref-type="bibr">38</xref>), whereas, HIF-1&#945;, and p53<sub>A</sub> encoding mRNAs utilize a CITE-like mechanism of translation.</p><p id="p0025">Beyond its role in translation, &#8764;30% of 4E-BP1 is nuclear and sequesters eIF4E, limiting its cytoplasmic availability (<xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>). The remaining (&#8764;70%) cytosolic 4E-BP1 is pivotal in facilitating a switch from cap-dependent to eIF4E-independent mRNA translation under hypoxia, promoting tumor angiogenesis and growth (<xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib42" ref-type="bibr">42</xref>). Despite its pivotal role in translation regulation, the specific mechanisms by which elevated 4E-BP1 levels influence IRES- and CITE-like translation initiation remain poorly understood. While previous studies have demonstrated that elevated 4E-BP1 enhanced the selective translation of IRES-containing mRNAs under hypoxia (<xref rid="bib43" ref-type="bibr">43</xref>), its impact on CITE-like mRNAs in response to stress or altered eIF levels is unclear. One potential mechanism is highlighted in a study by Haizel S. <italic toggle="yes">et al</italic>. (<xref rid="bib34" ref-type="bibr">34</xref>), which reported that a subset of 5&#8242;UTR-containing mRNAs, including FGF-9 (IRES-like) and HIF-1&#945; (CITE-like), utilize the direct recruitment of eIF4GI<sub>557-1599</sub> to their structured 5&#8242;UTRs to initiate translation. It is unclear whether eIF4E is sequestered by 4E-BP1 and is driven away from the translation initiation system, or whether, once sequestered, eIF4E in complex with 4E-BP1 (eIF4E&#8226;4E-BP1) remains bound to the 5&#8242; cap of the mRNA, directing eIF4GI<sub>557-1599</sub> to the 5&#8242;UTR to initiate translation. To address this knowledge gap, this study investigated how the mRNAs encoding HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> bypass 4E-BP1-mediated translational repression and whether eIF4GI<sub>557-1599</sub>&#8226;eIF4A or eIF4E can restore translation in these contexts. This study aims to differentiate IRES-like from CITE-like mechanism of translation under conditions of high 4E-BP1 expression. To systematically investigate these mechanisms, well-characterized functional (m<sup>7</sup>G-) or non-functional (ApppG-) capped reporter mRNAs with structured 5&#8242;UTRs were used to perform <italic toggle="yes">in-vitro</italic> translation assays and fluorescence anisotropy binding studies. As control, a capped, unstructured &#946;-actin-Luc mRNA was included, which relies strictly on cap-dependent translation, serving as a baseline for translational repression by 4E-BP1. By dissecting these mechanisms and providing quantitative binding data, these findings provide a foundation for targeting translation as a therapeutic strategy in cancer and other diseases characterized by dysregulated eIF4E-independent translation.</p><sec id="sec1"><title>Results</title><sec id="sec1.1"><title>4E-BP1 enhances eIF4E binding to 5&#8242;UTRs of mRNAs</title><p id="p0030">Previous research has suggested that 4E-BP1 sequesters eIF4E to prevent cap binding (<xref rid="bib44" ref-type="bibr">44</xref>) while other researchers have suggested the eIF4E&#8226;4E-BP1 complex binds to the cap to block translation initiation (<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib45" ref-type="bibr">45</xref>, <xref rid="bib46" ref-type="bibr">46</xref>, <xref rid="bib47" ref-type="bibr">47</xref>). To investigate these two possibilities, binding affinities of eIF4E, eIF4E&#8226;4E-BP1, and 4E-BP1 to m<sup>7</sup>G- or ApppG-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs were measured using a fluorescence-based anisotropy assay. Anisotropy values were normalized and plotted as a function of protein concentration.</p><p id="p0035">These binding data demonstrated that eIF4E&#8226;4E-BP1 exhibits differential binding to these mRNAs (<xref rid="tbl1" ref-type="table">Table 1</xref>). The eIF4E&#8226;4E-BP1 bound m<sup>7</sup>G-capped mRNAs with significantly higher affinity than eIF4E alone. For the 5&#8242;UTR of HIF-1&#945; mRNA, the equilibrium dissociation constant (K<sub>D</sub>) values decreased from (56 &#177; 1.5) nM with eIF4E alone to (15 &#177; 3.4) nM with the eIF4E&#8226;4E-BP1 (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig1" ref-type="fig">Fig. 1</xref><italic toggle="yes">B</italic>). Similarly, for the 5&#8242;UTR of p53<sub>A</sub> mRNA, the K<sub>D</sub> values decreased from (59 &#177; 7.5) nM to (13 &#177; 1.1) nM (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig1" ref-type="fig">Fig. 1</xref><italic toggle="yes">C</italic>). These results indicated that the eIF4E&#8226;4E-BP1 bound these mRNAs &#8764;4-5-fold more tightly than eIF4E alone, suggesting that 4E-BP1 enhanced eIF4Es mRNA-binding properties, potentially through structural (<xref rid="bib43" ref-type="bibr">43</xref>) or allosteric regulation of eIF4E conformation (<xref rid="bib47" ref-type="bibr">47</xref>). A more modest (&#8764;2-fold) increase in affinity was observed for 5&#8242;UTRs of FGF-9, and p53<sub>B</sub> mRNAs, with K<sub>D</sub> values decreasing from (72 &#177; 1.6) nM to (32 &#177; 3.9) nM, and from (54 &#177; 2.3) nM to (28 &#177; 2.3) nM, respectively (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig1" ref-type="fig">Fig. 1</xref>, <italic toggle="yes">D</italic> and <italic toggle="yes">E</italic>). Interestingly, 4E-BP1 alone did not bind any of these mRNAs, indicating that its mRNA association requires complex formation with eIF4E (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, <italic toggle="yes">B</italic>&#8211;<italic toggle="yes">E</italic>). As a control, the 5&#8242;UTR of m<sup>7</sup>G-capped &#946;-actin mRNA also showed increased binding affinity, with K<sub>D</sub> values decreasing from (28 &#177; 1.8) nM to (12 &#177; 0.6) nM (<xref rid="fig1" ref-type="fig">Fig. 1</xref><italic toggle="yes">A</italic>).<table-wrap position="float" id="tbl1" orientation="portrait"><label>Table 1</label><caption><p>Equilibrium dissociation constants K<sub>D</sub> (nM) for protein-m<sup>7</sup>G-mRNA</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Binding complex</th><th colspan="1" rowspan="1">m<sup>7</sup>G &#946;-actin mRNA<hr/></th><th colspan="2" rowspan="1">m<sup>7</sup>G HIF-1&#945; mRNA<hr/></th><th colspan="2" rowspan="1">m<sup>7</sup>G p<sup>53<sub>A</sub></sup> mRNA<hr/></th><th colspan="2" rowspan="1">m<sup>7</sup>G FGF-9 mRNA<hr/></th><th colspan="2" rowspan="1">m<sup>7</sup>Gp<sup>53<sub>B</sub></sup> mRNA<hr/></th></tr><tr><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">eIF4E</td><td colspan="1" rowspan="1">28 &#177; 1.8</td><td colspan="1" rowspan="1">56 &#177; 1.5</td><td align="char" colspan="1" rowspan="1">0.945</td><td colspan="1" rowspan="1">59 &#177; 7.5</td><td align="char" colspan="1" rowspan="1">0.957</td><td colspan="1" rowspan="1">72 &#177; 1.6</td><td align="char" colspan="1" rowspan="1">0.949</td><td colspan="1" rowspan="1">54 &#177; 2.3</td><td align="char" colspan="1" rowspan="1">0.996</td></tr><tr><td colspan="1" rowspan="1">eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">12 &#177; 0.6</td><td colspan="1" rowspan="1">15 &#177; 3.4</td><td align="char" colspan="1" rowspan="1">0.980</td><td colspan="1" rowspan="1">13 &#177; 1.1</td><td align="char" colspan="1" rowspan="1">0.979</td><td colspan="1" rowspan="1">32 &#177; 3.9</td><td align="char" colspan="1" rowspan="1">0.990</td><td colspan="1" rowspan="1">28 &#177; 2.3</td><td align="char" colspan="1" rowspan="1">0.963</td></tr><tr><td colspan="1" rowspan="1">4E-BP1</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNAs</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">22 &#177; 0.5</td><td align="char" colspan="1" rowspan="1">0.985</td><td colspan="1" rowspan="1">44 &#177; 1.0</td><td align="char" colspan="1" rowspan="1">0.987</td><td colspan="1" rowspan="1">20 &#177; 2</td><td align="char" colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1">18 &#177; 3.1</td><td align="char" colspan="1" rowspan="1">0.984</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNA&#8226; eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">15 &#177; 3.4</td><td align="char" colspan="1" rowspan="1">0.990</td><td colspan="1" rowspan="1">31 &#177; 5.9</td><td align="char" colspan="1" rowspan="1">0.960</td><td colspan="1" rowspan="1">24 &#177; 0.9</td><td align="char" colspan="1" rowspan="1">0.993</td><td colspan="1" rowspan="1">18 &#177; 0.3</td><td align="char" colspan="1" rowspan="1">0.995</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub>&#8226; eIF4A binding to mRNA&#8226; eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">20 &#177; 1.3</td><td align="char" colspan="1" rowspan="1">0.995</td><td colspan="1" rowspan="1">33 &#177; 0.7</td><td align="char" colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">23 &#177; 1.3</td><td align="char" colspan="1" rowspan="1">0.991</td><td colspan="1" rowspan="1">21 &#177; 2.2</td><td align="char" colspan="1" rowspan="1">0.993</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub>&#8226; eIF4A&#8226;ATP binding to mRNA&#8226;eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">21 &#177; 0.5</td><td align="char" colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1">35 &#177; 1.3</td><td align="char" colspan="1" rowspan="1">0.995</td><td colspan="1" rowspan="1">24 &#177; 1.5</td><td align="char" colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1">22 &#177; 1.1</td><td align="char" colspan="1" rowspan="1">0.998</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNA bound eIF4E&#8226;4E-BP1-FITC-Peptide</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1">21 &#177; 0.7</td><td align="char" colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">29 &#177; 1.3</td><td align="char" colspan="1" rowspan="1">0.985</td><td colspan="1" rowspan="1">32 &#177; 0.3</td><td align="char" colspan="1" rowspan="1">0.990</td><td colspan="1" rowspan="1">47 &#177; 0.7</td><td align="char" colspan="1" rowspan="1">0.993</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>K<sub>D</sub> is the dissociation constant.</p></fn><fn id="tspara0020"><p><italic toggle="yes">&#967;</italic><sup>2</sup> represents the goodness of fit. NSB, no significant binding.</p></fn></table-wrap-foot></table-wrap><fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Fluorescence anisotropy analyses of eIF4E and eIF4E&#8226;4E-BP1 binding to m<sup>7</sup>G-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs</bold>. Normalized anisotropy changes (denoted as r&#772;) for the interaction of eIF4E (-&#9642;-), eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx11.gif"/>), and 4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx12.gif"/>) with 10 nM m<sup>7</sup>G-capped 5&#8242;UTR of (<italic toggle="yes">A</italic>) &#946;-Actin (control), (<italic toggle="yes">B</italic>) HIF-1&#945;, (<italic toggle="yes">C</italic>) p53<sub>A</sub>, (<italic toggle="yes">D</italic>) FGF-9 and (<italic toggle="yes">E</italic>) p53<sub>B</sub> encoding mRNA transcripts fluorescein-labeled at 3&#8242;terminus, respectively. Data points corresponding to the average from three independent anisotropy measurements were normalized and plotted against protein concentration (&#956;M). Curves represent Hill-equation fits, as described in materials and methods, used to calculate the corresponding K<sub>D</sub> values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><p id="p0040">To further elucidate the mechanism of 4E-BP1-mediated translation regulation, protein interactions with non-functional ApppG-capped mRNAs were also examined. Like m<sup>7</sup>G-capped mRNA constructs, the eIF4E&#8226;4E-BP1 bound more tightly to ApppG-capped mRNAs than eIF4E alone. For example, binding affinities to the 5&#8242;UTRs of HIF-1&#945;, and p53<sub>A</sub> encoding mRNAs increased &#8764;4-fold, with K<sub>D</sub> values decreasing from (199 &#177; 1.5) nM to (52 &#177; 0.5) nM, and from (186 &#177; 0.8) nM to (45 &#177; 1.6) nM, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="fig2" ref-type="fig">Fig. 2</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>). This enhanced binding affinity suggested that the eIF4E&#8226;4E-BP1 recognizes additional mRNA features beyond the m<sup>7</sup>G-cap. Although eIF4E is primarily known for its specificity to the m<sup>7</sup>G-cap (<xref rid="bib48" ref-type="bibr">48</xref>, <xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib50" ref-type="bibr">50</xref>, <xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>), prior studies have shown it can also interact with other mRNA elements (<xref rid="bib48" ref-type="bibr">48</xref>).<table-wrap position="float" id="tbl2" orientation="portrait"><label>Table 2</label><caption><p>Equilibrium dissociation constants K<sub>D</sub> (nM) for protein-ApppG-mRNA</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Binding complex</th><th colspan="2" rowspan="1">ApppG HIF-1&#945; mRNA<hr/></th><th colspan="2" rowspan="1">ApppG p<sub>53A</sub> mRNA<hr/></th><th colspan="2" rowspan="1">ApppG FGF-9 mRNA<hr/></th><th colspan="2" rowspan="1">ApppG p<sub>53B</sub> mRNA<hr/></th></tr><tr><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th><th colspan="1" rowspan="1">K<sub>D</sub> (nM)</th><th colspan="1" rowspan="1"><italic toggle="yes">&#967;</italic><sup>2</sup></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">eIF4E</td><td colspan="1" rowspan="1">199 &#177; 1.5</td><td align="char" colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">186 &#177; 0.8</td><td align="char" colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">138 &#177; 4.6</td><td align="char" colspan="1" rowspan="1">0.991</td><td colspan="1" rowspan="1">159 &#177; 4.2</td><td align="char" colspan="1" rowspan="1">0.998</td></tr><tr><td colspan="1" rowspan="1">eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">52 &#177; 0.5</td><td align="char" colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">45 &#177; 1.6</td><td align="char" colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">87 &#177; 2.0</td><td align="char" colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">89 &#177; 3.5</td><td align="char" colspan="1" rowspan="1">0.990</td></tr><tr><td colspan="1" rowspan="1">4E-BP1</td><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">NSB</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNAs</td><td colspan="1" rowspan="1">67 &#177; 1.8</td><td align="char" colspan="1" rowspan="1">0.975</td><td colspan="1" rowspan="1">81 &#177; 1.3</td><td align="char" colspan="1" rowspan="1">0.977</td><td colspan="1" rowspan="1">28 &#177; 0.7</td><td align="char" colspan="1" rowspan="1">0.995</td><td colspan="1" rowspan="1">66 &#177; 1.7</td><td align="char" colspan="1" rowspan="1">0.990</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNA&#8226; eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">25 &#177; 1.8</td><td align="char" colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">25 &#177; 1.1</td><td align="char" colspan="1" rowspan="1">0.994</td><td colspan="1" rowspan="1">13 &#177; 0.6</td><td align="char" colspan="1" rowspan="1">0.993</td><td colspan="1" rowspan="1">22 &#177; 0.8</td><td align="char" colspan="1" rowspan="1">0.995</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub>&#8226; eIF4A binding to mRNA&#8226; eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">19 &#177; 0.6</td><td align="char" colspan="1" rowspan="1">0.994</td><td colspan="1" rowspan="1">20 &#177; 2.0</td><td align="char" colspan="1" rowspan="1">0.991</td><td colspan="1" rowspan="1">15 &#177; 0.3</td><td align="char" colspan="1" rowspan="1">0.994</td><td colspan="1" rowspan="1">28 &#177; 1.8</td><td align="char" colspan="1" rowspan="1">0.984</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub>&#8226; eIF4A&#8226;ATP binding to mRNA&#8226; eIF4E&#8226;4E-BP1</td><td colspan="1" rowspan="1">24 &#177; 4.3</td><td align="char" colspan="1" rowspan="1">0.987</td><td colspan="1" rowspan="1">16 &#177; 0.8</td><td align="char" colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">18 &#177; 1.0</td><td align="char" colspan="1" rowspan="1">0.994</td><td colspan="1" rowspan="1">21 &#177; 1.1</td><td align="char" colspan="1" rowspan="1">0.990</td></tr><tr><td colspan="1" rowspan="1">eIF4GI<sub>557-1599</sub> binding to mRNA bound eIF4E&#8226;4E-BP1-FITC-Peptide</td><td colspan="1" rowspan="1">30 &#177; 3.1</td><td align="char" colspan="1" rowspan="1">0.978</td><td colspan="1" rowspan="1">35 &#177; 0.5</td><td align="char" colspan="1" rowspan="1">0.994</td><td colspan="1" rowspan="1">25 &#177; 1.0</td><td align="char" colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">42 &#177; 2.0</td><td align="char" colspan="1" rowspan="1">0.996</td></tr></tbody></table><table-wrap-foot><fn id="tspara0030"><p>K<sub>D</sub> is the dissociation constant.</p></fn><fn id="tspara0035"><p><italic toggle="yes">&#967;</italic><sup>2</sup> represents the goodness of fit. NSB, no significant binding.</p></fn></table-wrap-foot></table-wrap><fig id="fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>Fluorescence anisotropy analyses of eIF4E and eIF4E&#8226;4E-BP1 binding to ApppG-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs</bold>. Normalized anisotropy changes (denoted as r&#772;) for the interaction of eIF4E (-&#9642;-), eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx11.gif"/>), and 4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx12.gif"/>) with 10 nM ApppG-capped 5&#8242;UTR of (<italic toggle="yes">A</italic>) HIF-1&#945;, (<italic toggle="yes">B</italic>) p53<sub>A</sub>, (<italic toggle="yes">C</italic>) FGF-9, and (<italic toggle="yes">D</italic>) p53<sub>B</sub> encoding mRNA transcripts fluorescein-labeled at 3&#8242;terminus, respectively. Data points corresponding to the average from three independent anisotropy measurements were normalized and plotted against protein concentration (&#956;M). Curves represent Hill-equation fits, as described in materials and methods, used to calculate the corresponding K<sub>D</sub> values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="p0045">Similarly, the presence of 4E-BP1-enhanced eIF4E&#8217;s binding to ApppG-capped 5&#8242;UTRs of FGF-9, and p53<sub>B</sub> encoding mRNAs, leading to a &#8764;2-fold increase in binding affinity. In this case, K<sub>D</sub> values decreased from (138 &#177; 4.6) nM to (87 &#177; 2.0) nM for 5&#8242;UTR of FGF-9 mRNA, and from (159 &#177; 4.2) nM to (89 &#177; 3.5) nM for 5&#8242;UTR of p53<sub>B</sub> mRNA (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="fig2" ref-type="fig">Fig. 2</xref>, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>). Notably, the eIF4E&#8226;4E-BP1 consistently bound more tightly to functional m<sup>7</sup>G-capped than to non-functional ApppG-capped mRNAs across all constructs (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>). This effect was especially pronounced in CITE-like mRNAs.</p></sec><sec id="sec1.2"><title>4E-BP1 differentially affects the translation of CITE-like mRNAs and IRES-like mRNAs</title><p id="p0050">In general, 4E-BP1 regulates cell proliferation and survival by modulating translation of specific mRNA subsets (<xref rid="bib53" ref-type="bibr">53</xref>, <xref rid="bib54" ref-type="bibr">54</xref>). To investigate its role in eIF4E-independent translation of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub>-UTR-Luc mRNAs respectively, <italic toggle="yes">in-vitro</italic> translation assays were performed using nuclease-treated rabbit reticulocyte lysate (RRL) under cap-dependent translation conditions. &#946;-actin-UTR-Luc mRNA, which is strictly cap-dependent under these conditions (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib55" ref-type="bibr">55</xref>), served as a control to validate the cap-dependency of our system. To corelate binding affinity of the eIF4E&#8226;4E-BP1 with its translational output, luciferase reporter mRNAs containing the respective 5&#8242;UTRs (UTR-Luc) were synthesized with either m<sup>7</sup>G- or ApppG-caps (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">A</italic>), the latter serving as a non-functional cap to protect the 5&#8242; end from degradation. Although the eIF4E&#8226;4E-BP1 can associate with both cap structures, binding to m<sup>7</sup>G-capped mRNAs was significantly tighter (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>, <xref rid="fig1" ref-type="fig">Fig. 1</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">E</italic>, and <xref rid="fig2" ref-type="fig">2</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>). For CITE-like mRNAs, the relative luciferase expression markedly decreased in response to increasing 4E-BP1 concentrations. As the concentration of 4E-BP1 increases, the relative expression level of m<sup>7</sup>G-capped HIF-1&#945;-UTR-Luc mRNA declined to less than &#8764;20% of its maximum, while the ApppG-capped transcripts were reduced even further to &#8764;5%, relative to its m<sup>7</sup>G-capped analogs (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">C</italic>). Similarly, translation of m<sup>7</sup>G-capped p53<sub>A</sub>-UTR-Luc mRNA declined to less than &#8764;36%, while the ApppG-capped transcript was reduced even further to &#8764;3%, relative to its m<sup>7</sup>G-capped counterparts (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">D</italic>). Although ApppG-capped mRNAs followed a similar inhibition trend compared to m<sup>7</sup>G-capped analogs, their baseline expression was inherently lower than the m<sup>7</sup>G-capped analogs. These results aligned well with earlier reports indicating a direct correlation between binding affinity and translation efficiency (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib56" ref-type="bibr">56</xref>). Given that CITE-like mRNAs require a free 5&#8242;end (<xref rid="bib43" ref-type="bibr">43</xref>) and likely 5&#8242;end scanning (<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib58" ref-type="bibr">58</xref>), the tighter binding of the eIF4E&#8226;4E-BP1 than eIF4E alone near the 5&#8242;cap or critical regions of the mRNAs, may form a steric barrier that impedes 43S PIC recruitment and scanning (<xref rid="bib27" ref-type="bibr">27</xref>), thereby inhibiting translation initiation and potentially preventing tumor formation (<xref rid="bib59" ref-type="bibr">59</xref>).<fig id="fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><bold>4E-BP1 effects on the translation yields of m<sup>7</sup>G- and ApppG-capped-5&#8242;UTR-Luc mRNAs</bold>. <italic toggle="yes">A</italic>, Cartoon representation of the mRNA reporter used for this study. Translation yields of (<italic toggle="yes">B</italic>) m<sup>7</sup>G-&#946;-actin-UTR-Luc mRNA; Comparison of m<sup>7</sup>G- and ApppG-capped transcripts of (<italic toggle="yes">C</italic>) HIF-1&#945;; (<italic toggle="yes">D</italic>) p53<sub>A</sub>, (<italic toggle="yes">E</italic>) FGF-9, and (<italic toggle="yes">F</italic>) p53<sub>B</sub>-UTR-Luc encoding mRNAs following addition of increasing concentrations of 4E-BP1. Relative luciferase activity was normalized to the respective controls (m<sup>7</sup>G-capped-UTR-Luc mRNA) for each reporter constructs with no 4E-BP1 added to non-depleted RRL. Diagonally <italic toggle="yes">striped bar</italic> (-<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx1.gif"/>-), represents m<sup>7</sup>G-capped mRNAs; and <italic toggle="yes">white bar</italic> (-<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx2.gif"/>-), represents ApppG-capped RNAs, respectively. Bar heights and error bars correspond to the average and standard deviations, respectively, of three independent luciferase activity measurements. Data were analyzed by two-tailed unpaired Student&#8217;s <italic toggle="yes">t</italic> test, where p represents the probability that differences occurred by chance: n.s, p = 0.12; &#8727;, p &lt; 0.033; &#8727;&#8727;, p = 0.002; &#8727;&#8727;&#8727;, p &lt; 0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p><p id="p0055">Unlike CITE-like mRNAs, the translation efficiency of m<sup>7</sup>G-capped IRES-like mRNAs was only modestly affected by 4E-BP1. For m<sup>7</sup>G-capped FGF-9-UTR-Luc mRNA, the translation efficiency was slightly reduced to &#8764;85% in the presence of 4E-BP1 (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">E</italic>). Similarly, m<sup>7</sup>G-capped p53<sub>B</sub>-UTR-Luc mRNA showed a minor reduction to &#8764;87% (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">F</italic>). In contrast, the ApppG-capped versions of these mRNAs, while inherently less efficient than their m<sup>7</sup>G-capped counterparts, exhibited little to no further inhibition by 4E-BP1, even at 50 nM 4E-BP1 (<xref rid="fig3" ref-type="fig">Fig. 3</xref>, <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>). These findings suggest that ApppG-capped IRES-like mRNAs, despite lower basal level of translation, are largely resistant to 4E-BP1-mediated translation inhibition. This supports the notion that eIF4E sequestration by 4E-BP1 doesn&#8217;t block cap-independent translation driven by the 5&#8242;UTRs of FGF-9, and p53<sub>B</sub> encoding mRNAs. This is consistent with prior research in HEK293 T cells under stress, where activation of endogenous 4E-BP1 didn&#8217;t significantly impair translation of IRES-containing viral mRNAs (<xref rid="bib38" ref-type="bibr">38</xref>). For the control, m<sup>7</sup>G-capped-&#946;-actin-UTR-Luc mRNA, translation efficiency was significantly reduced to &#8764;25% by 4E-BP1 (<xref rid="fig3" ref-type="fig">Fig. 3</xref><italic toggle="yes">B</italic>), in line with prior findings showing a &#8764;2.5-fold reduction of cap-dependent translation upon 4E-BP1 overexpression (<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib60" ref-type="bibr">60</xref>). Conversely, the ApppG-capped-&#946;-actin mRNA transcript showed &lt;2% activity compared to its m<sup>7</sup>G-capped counterpart (<xref rid="appsec1" ref-type="sec">Fig. S1</xref>), confirming the inefficiency of cap-independent translation for strictly cap-dependent mRNAs (<xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib55" ref-type="bibr">55</xref>). Together, these data demonstrated that 4E-BP1 differentially regulated cap-independent translation, strongly inhibiting translation of CITE-like mRNAs that require a 5&#8242;end access, while exerting minimal effects on IRES-like mRNAs that initiate translation in a 5&#8242;end independent manner.</p></sec><sec id="sec1.3"><title>4E-BP1-4Ala and wild-type 4E-BP1 similarly inhibit cap-dependent mRNA translation under hypo-phosphorylated conditions</title><p id="p0060">To address the possibility that the observed effect of 4E-BP1 on each subset of mRNAs was due to its hypo-phosphorylation during purification or the assay, the effects of wild-type 4E-BP1 and a 4E-BP1 mutant with Ala substitution at phosphorylation sites were compared. A dominant negative control, a 4E-BP1 mutant that is constitutively hypo-phosphorylated with four negative regulatory phosphorylation sites on 4E-BP1 mutated to Ala (T37 A, T46 A, S65 A, T70 A), referred to as 4E-BP1-4Ala (an exogenous non-phosphorylated form of 4E-BP1) (<xref rid="bib61" ref-type="bibr">61</xref>) was used. This mutant is basically immune to being shut off by mTOR-mediated phosphorylation and therefore is very active at binding eIF4E regardless of cellular stress conditions. To assess its functional impact, the effects of increasing concentrations of 4E-BP1-4Ala and wild-type 4E-BP1 on the relative expression level of m<sup>7</sup>G-capped HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub>-UTR-Luc mRNAs were compared. There were no significant changes in the expression levels of these mRNAs across comparable concentrations of the two proteins (4E-BP1-4Ala, and wild-type 4E-BP1) (<xref rid="appsec1" ref-type="sec">Fig. S2</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>). A similar trend was observed for ApppG-capped UTR-Luc mRNAs (<xref rid="appsec1" ref-type="sec">Fig. S3</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>). These findings indicated that wild-type 4E-BP1 remained hypo-phosphorylated under these experimental conditions, effectively mimicking the natural stress conditions necessary for eIF4E-independent translation initiation.</p></sec><sec id="sec1.4"><title>eIF4E partially restored 4E-BP1-mediated inhibition of CITE-like mRNA translation but has minimal effect on IRES-like mRNAs</title><p id="p0065">Since 4E-BP1 sequesters eIF4E and limits its availability (<xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib62" ref-type="bibr">62</xref>), and eIF4E is crucial for cap-independent translation initiation (<xref rid="bib24" ref-type="bibr">24</xref>), the effect of exogenously added eIF4E was tested in non-eIF4E-depleted cells while maintaining a constant 50 nM 4E-BP1 concentration. For m<sup>7</sup>G-capped CITE-like HIF-1&#945;-UTR-Luc, and p53<sub>A</sub>-UTR-Luc mRNAs, increasing eIF4E concentrations (up to 150 nM), partially restored translation under constant 50 nM 4E-BP1 conditions. Translation of HIF-1&#945;-UTR-Luc, and p53<sub>A</sub>-UTR-Luc mRNAs increased from &lt;20% and &lt;36% at 0 nM added eIF4E in the presence of 50 nM 4E-BP1 to &#8764;53% and &#8764;75% at 150 nM additional eIF4E, respectively (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>). Notably, eIF4E could not fully restore translation to baseline levels, likely because its binding affinity for these mRNAs is &#8764;4-fold lower compared to the eIF4E&#8226;4E-BP1 (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, <italic toggle="yes">B</italic>&#8211;<italic toggle="yes">C</italic>, and <xref rid="fig2" ref-type="fig">2</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">B</italic>). Similar results were observed with ApppG-capped constructs, where eIF4E partially restored the translation of CITE-like HIF-1&#945;-UTR-Luc, and p53<sub>A</sub>-UTR-Luc mRNAs increasing expression from &#8764;15% and &#8764;17% (at 0 nM added eIF4E) to &#8764;54% and &#8764;56% (at 150 nM added eIF4E), respectively (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>). In contrast, for m<sup>7</sup>G-capped IRES-like FGF-9-UTR-Luc, and p53<sub>B</sub>-UTR-Luc mRNAs, the mild inhibition observed with 50 nM 4E-BP1 wasn&#8217;t improved by eIF4E addition, whether the transcripts were m<sup>7</sup>G- or ApppG-capped (<xref rid="fig4" ref-type="fig">Figure 4</xref>, <italic toggle="yes">C</italic>&#8211;<italic toggle="yes">D</italic> and <italic toggle="yes">G</italic>&#8211;<italic toggle="yes">H</italic>). These differences are likely due to unique 5&#8242;UTR features that influence eIF recruitment (<xref rid="bib63" ref-type="bibr">63</xref>). For the control, m<sup>7</sup>G-capped-&#946;-actin-UTR-Luc mRNA, addition of equimolar amount of 4E-BP1 and purified eIF4E significantly restored translation from &#8764;25% to &#8764;80% in the presence of 50 nM 4E-BP1 (<xref rid="appsec1" ref-type="sec">Fig. S4</xref><italic toggle="yes">A</italic>), consistent with prior reports (<xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib65" ref-type="bibr">65</xref>, <xref rid="bib66" ref-type="bibr">66</xref>). Overall, these results support a model in which eIF4E availability selectively modulates the translation of CITE-like mRNAs, while IRES-like mRNAs remain largely insensitive to eIF4E levels, likely due to their cap-independent mechanisms of 43S PIC recruitment.<fig id="fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><p><bold>Effect of eIF4E on the translation yields of m<sup>7</sup>G- and ApppG-capped HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub>-5&#8242;UTR-Luc mRNA transcripts</bold>. Translation yields of m<sup>7</sup>G-capped (<italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>) and ApppG-capped (<italic toggle="yes">E</italic>&#8211;<italic toggle="yes">H</italic>) mRNA transcripts of HIF-1&#945;-, p53<sub>A</sub>-, FGF-9-, and p53<sub>B</sub>-UTR-Luc mRNAs, respectively, following treatment of the RRL with 50 nM of 4E-BP1 and increasing concentrations of eIF4E. Conditions included 50 nM (denoted as +), and 150 nM (denoted as ++) of eIF4E. For m<sup>7</sup>G-capped mRNAs, 4E-BP1 alone (<italic toggle="yes">diagonally striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx3.gif"/>-); increasing eIF4E concentration (<italic toggle="yes">vertically striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx4.gif"/>-). For ApppG-capped mRNAs, 4E-BP1 alone (<italic toggle="yes">white bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx5.gif"/>-); increasing eIF4E concentration (<italic toggle="yes">vertically striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx6.gif"/>-).4E-BP1 was held constant at 50 nM in all conditions. Relative luciferase activity was normalized to the respective controls (ApppG-capped-UTR-Luc mRNA) for each reporter constructs with no 4E-BP1 added to RRL. Bar heights and error bars correspond to the average and standard deviations, respectively, of three independent luciferase activity measurements. Data were analyzed by two-tailed unpaired Student&#8217;s t test, where p represents the probability that differences occurred by chance: n.s, p = 0.12; &#8727;, p &lt; 0.033; &#8727;&#8727;, p = 0.002; &#8727;&#8727;&#8727;, p &lt; 0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr4.jpg"/></fig></p></sec><sec id="sec1.5"><title>eIF4GI<sub>557-1599</sub>&#8226;eIF4A efficiently restored 4E-BP1-mediated inhibition of CITE-like mRNA translation but has minimal effect on IRES-like mRNAs</title><p id="p0070">Given that eIF4GI<sub>557-1599</sub> can directly bind mRNAs (<xref rid="bib34" ref-type="bibr">34</xref>), recruit the 43S PIC (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib43" ref-type="bibr">43</xref>), and promote cap-independent translation of both IRES-like (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib67" ref-type="bibr">67</xref>) and CITE-like mRNAs (<xref rid="bib34" ref-type="bibr">34</xref>), its role in overcoming 4E-BP1-mediated translational inhibition was evaluated. Because eIF4A functions as a helicase partner of eIF4GI<sub>557-1599</sub> within the eIF4F complex, facilitating mRNA remodeling and 43S PIC recruitment (<xref rid="bib68" ref-type="bibr">68</xref>, <xref rid="bib69" ref-type="bibr">69</xref>), both factors were tested in combination (hereafter, denoted as eIF4GI<sub>557-1599</sub>&#8226;eIF4A) to assess whether it could restore the 4E-BP1-mediated translation inhibition. To evaluate this, relative luciferase activity was measured from m<sup>7</sup>G-capped UTR-Luc reporter mRNAs in the presence of 50 nM 4E-BP1 and increasing concentrations of eIF4GI<sub>557-1599</sub>&#8226;eIF4A (added at a 1:1 M ratio to allow optimal complex formation). For CITE-like HIF-1&#945;-UTR-Luc, and p53<sub>A</sub>-UTR-Luc mRNAs, translation was significantly restored with increasing concentrations of eIF4GI<sub>557-1599</sub>&#8226;eIF4A, with relative luciferase activity increasing from &#8764;20% and &#8764;36% (at 0 nM added eIF4GI<sub>557-1599</sub>&#8226;eIF4A) to &#8764;82% and &#8764;85% respectively (at 150 nM added eIF4GI<sub>557-1599</sub>&#8226;eIF4A) (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>). A comparable pattern was observed for the ApppG-capped versions of these transcripts, where translation was restored from &#8764;15% and &#8764;17% to &#8764;61% and &#8764;80%, respectively (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>). These results demonstrated a &#8764;4-5-fold increase in translation of CITE-like mRNAs, highlighting that eIF4GI<sub>557-1599</sub>, in concert with eIF4A, can overcome 4E-BP1-mediated translation repression and promote cap-independent translation. This is consistent with previous reports showing eIF4GI<sub>557-1599</sub>&#8226;eIF4A interaction responsible for 43S PIC recruitment enhances cap-independent translation of viral mRNAs (<xref rid="bib66" ref-type="bibr">66</xref>, <xref rid="bib70" ref-type="bibr">70</xref>, <xref rid="bib71" ref-type="bibr">71</xref>).<fig id="fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><p><bold>Effect of eIF4GI<sub>557-1599</sub></bold>&#8226;<bold>eIF4A on the translation yields of m<sup>7</sup>G- and ApppG-capped HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub>-5&#8242;UTR-Luc mRNA transcripts</bold>. Translation yields of m<sup>7</sup>G-capped (<italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>) and ApppG-capped (<italic toggle="yes">E</italic>&#8211;<italic toggle="yes">H</italic>) mRNA transcripts of HIF-1&#945;-, p53<sub>A</sub>-, FGF-9-, and p53<sub>B</sub>-UTR-Luc mRNAs, respectively, following treatment of the RRL with 50 nM of 4E-BP1 and increasing concentrations of eIF4GI<sub>557-1599</sub>&#8226;eIF4A (added at a 1:1 M ratio). Conditions included 50 nM (denoted as +), and 150 nM (denoted as ++) of eIF4GI<sub>557-1599</sub>&#8226;eIF4A. For m<sup>7</sup>G-capped mRNAs, 4E-BP1 alone (<italic toggle="yes">diagonally striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx7.gif"/>-); increasing eIF4GI&#8226;eIF4A concentration (<italic toggle="yes">horizontally striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx8.gif"/>-). For ApppG-capped mRNAs, 4E-BP1 alone (<italic toggle="yes">white bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx9.gif"/>-); increasing eIF4GI&#8226;eIF4A concentration (<italic toggle="yes">horizontally striped bar</italic>, -<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx10.gif"/>-). 4E-BP1 was held constant at 50 nM in all conditions. Relative luciferase activity was normalized to the respective controls (m<sup>7</sup>G-capped-UTR-Luc mRNA) for each reporter constructs with no 4E-BP1 added to RRL. Bar heights and error bars correspond to the average and standard deviations, respectively, of three independent luciferase activity measurements. Data were analyzed by two-tailed unpaired Student&#8217;s <italic toggle="yes">t</italic> test, where p represents the probability that differences occurred by chance: n.s, p = 0.12; &#8727;, p &lt; 0.033; &#8727;&#8727;, p = 0.002; &#8727;&#8727;&#8727;, p &lt; 0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr5.jpg"/></fig></p><p id="p0075">In contrast, the translation of IRES-like FGF-9-UTR-Luc, and p53<sub>B</sub>-UTR-Luc mRNAs in the presence of 50 nM 4E-BP1 was minimally affected by eIF4GI<sub>557-1599</sub>&#8226;eIF4A addition, indicating that these mRNAs may rely on an alternative mode of initiation&#8212;potentially scaffold- or helicase-driven&#8212;distinct from the eIF4E-dependent pathway. For both m<sup>7</sup>G- and ApppG-capped FGF-9-UTR-Luc, and p53<sub>B</sub>-UTR-Luc mRNAs, the modest inhibition observed with 4E-BP1 was not alleviated by increasing concentrations of eIF4GI<sub>557-1599</sub>&#8226;eIF4A (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, <italic toggle="yes">C</italic>&#8211;<italic toggle="yes">D</italic>, and <italic toggle="yes">G</italic>&#8211;<italic toggle="yes">H</italic>). As a control, m<sup>7</sup>G-capped &#946;-actin-UTR-Luc mRNA was used which exhibited modest changes in relative luciferase activity upon eIF4GI<sub>557-1599</sub>&#8226;eIF4A addition (<xref rid="appsec1" ref-type="sec">Fig. S5</xref>), consistent with prior reports (<xref rid="bib66" ref-type="bibr">66</xref>).</p></sec><sec id="sec1.6"><title>Complexed with eIF4E&#8226;4E-BP1 but increased affinity for ApppG-capped mRNAs.eIF4GI<sub>557-1599</sub> alone or in complex with eIF4A shows comparable binding affinity for m<sup>7</sup>G-capped mRNAs</title><p id="p0080">While earlier studies have shown that eIF4GI<sub>557-1599</sub> can directly bind mRNAs (<xref rid="bib34" ref-type="bibr">34</xref>), the effect of the eIF4E&#8226;4E-BP1 on this interaction has not been fully explored. To address this, normalized fluorescence anisotropy assays were performed using m<sup>7</sup>G- or ApppG-capped 5&#8242;UTRs derived from HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs. eIF4GI<sub>557-1599</sub> binding was assessed both to free mRNA and to mRNA pre-assembled with eIF4E and 4E-BP1 (hereafter referred to as the mRNA&#8226;eIF4E&#8226;4E-BP1 ternary complex). Anisotropy values were plotted as a function of increasing eIF4GI<sub>557-1599</sub> concentration, either alone or in complex with eIF4A &#177; ATP, where ATP was included to test nucleotide-dependent effects on binding.</p><p id="p0085">For m<sup>7</sup>G-capped mRNAs, eIF4GI<sub>557-1599</sub> exhibited comparable binding affinities across all conditions tested. For the m<sup>7</sup>G-capped HIF-1&#945; 5&#8242;UTR mRNA, the K<sub>D</sub> values were (22 &#177; 0.5) nM for mRNA alone and (15 &#177; 3.4) nM when the mRNA was pre-bound by eIF4E&#8226;4E-BP1, with minimal changes upon addition of eIF4A or eIF4A&#8226;ATP to eIF4GI<sub>557-1599</sub> (20 &#177; 1.3, and 21 &#177; 1.5 nM, respectively). The m<sup>7</sup>G-capped p53<sub>A</sub> 5&#8242;UTR mRNA showed similar behavior, with K<sub>D</sub> values of (44 &#177; 3.1) nM (mRNA alone), (31 &#177; 5.9) nM (mRNA&#8226;eIF4E&#8226;4E-BP1 bound), and minor changes with eIF4A or eIF4A&#8226;ATP (33 &#177; 0.7, and 35 &#177; 1.3 nM, respectively). (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig6" ref-type="fig">Fig. 6</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>). For the m<sup>7</sup>G-capped FGF-9 5&#8242;UTR mRNA, K<sub>D</sub> values were (20 &#177; 2.0) nM (mRNA alone) and (24 &#177; 0.9) nM (mRNA&#8226;eIF4E&#8226;4E-BP1 bound), with negligible effects from eIF4A or eIF4A ATP (23 &#177; 1.3, and 24 &#177; 1.5 nM, respectively). Similarly, the m<sup>7</sup>G-capped p53<sub>B</sub> 5&#8242;UTR mRNA showed K<sub>D</sub> values of (18 &#177; 3.1) nM (mRNA alone), (18 &#177; 0.3) nM (mRNA&#8226;eIF4E&#8226;4E-BP1 bound), and (21 &#177; 2.2, and 22 &#177; 1.1 nM, respectively) with eIF4A or eIF4A&#8226;ATP (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig6" ref-type="fig">Fig. 6</xref>, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>). These results likely suggest that for m<sup>7</sup>G-capped mRNAs, eIF4GI<sub>557-1599</sub> can bind directly to the mRNA at sites distinct from the cap-bound eIF4E&#8226;4E-BP1 complex, resulting in largely unchanged affinities<fig id="fig6" position="float" orientation="portrait"><label>Figure 6</label><caption><p><bold>Fluorescence anisotropy analyses of eIF4GI<sub>557-1599</sub> (alone or in complex with eIF4A</bold> &#177; <bold>ATP) binding to m<sup>7</sup>G-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs either alone or as part of the mRNA</bold>&#8226;<bold>eIF4E</bold>&#8226;<bold>4E-BP1 ternary complex</bold>. Normalized anisotropy changes (denoted as r&#772;) for the interaction of eIF4GI<sub>557-1599</sub> binding to mRNAs alone (-&#9642;-) and mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx11.gif"/>); eIF4GI<sub>557-1599</sub>&#8226;eIF4A binding to mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx12.gif"/>), and eIF4GI<sub>557-1599</sub>&#8226;eIF4A&#8226;ATP to mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx13.gif"/>) with 10 nM m<sup>7</sup>G-capped 5&#8242;UTR of (<italic toggle="yes">A</italic>) HIF-1&#945;, (<italic toggle="yes">B</italic>) p53<sub>A</sub>, (<italic toggle="yes">C</italic>) FGF-9 and (<italic toggle="yes">D</italic>) p53<sub>B</sub> encoding mRNA transcripts fluorescein-labeled at 3&#8242;terminus, respectively. Data points corresponding to the average from three independent anisotropy measurements were normalized and plotted against protein concentration (&#956; M). Curves represent Hill-equation fits, as described in materials and methods, used to calculate the corresponding K<sub>D</sub> values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr6.jpg"/></fig></p><p id="p0090">Unlike m<sup>7</sup>G-capped mRNAs, where eIF4GI<sub>557-1599</sub> binding remained largely unchanged, ApppG-capped mRNAs exhibited enhanced binding. For the ApppG-capped 5&#8242;UTR of HIF-1&#945; mRNA, the K<sub>D</sub> values decreased from (67 &#177; 1.8) nM for mRNA alone to (25 &#177; 1.8) nM when mRNA was pre-bound by the eIF4E&#8226;4E-BP1 and was (19 &#177; 0.6) nM and (24 &#177; 4.3) nM when eIF4GI<sub>557-1599</sub> was complexed with eIF4A or eIF4A&#8226;ATP, respectively. Likewise, for the ApppG-capped p53<sub>A</sub> 5&#8242;UTR mRNA, the K<sub>D</sub> values decreased from (81 &#177; 1.3) nM to (25 &#177; 1.1) nM and was (20 &#177; 2.0) nM and (16 &#177; 0.8) nM when eIF4GI<sub>557-1599</sub> was complexed with eIF4A or eIF4A&#8226;ATP, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="fig7" ref-type="fig">Fig. 7</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>). These results indicated a &#8764;3-4-fold increase in eIF4GI<sub>557-1599</sub> binding affinity upon mRNA&#8226;eIF4E&#8226;4E-BP1 ternary complex formation. Enhanced eIF4GI<sub>557-1599</sub> binding was also evident for the ApppG-capped 5&#8242;UTRs of FGF-9, and p53<sub>B</sub> mRNAs. The K<sub>D</sub> values for the 5&#8242;UTR of FGF-9 mRNA decreased from (28 &#177; 0.7) nM for mRNA alone to (13 &#177; 0.6) nM in the presence of the eIF4E&#8226;4E-BP1 and was (15 &#177; 1.0) nM and (18 &#177; 1.0) nM when eIF4GI<sub>557-1599</sub> was complexed with eIF4A or eIF4A&#8226;ATP, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="fig7" ref-type="fig">Fig. 7</xref><italic toggle="yes">C</italic>). Similarly, for the ApppG-capped 5&#8242;UTR of p53<sub>B</sub> mRNA, the K<sub>D</sub> values decreased from (66 &#177; 1.7) nM, to (22 &#177; 0.8) nM and was (28 &#177; 1.8) nM and (21 &#177; 1.1) nM when eIF4GI<sub>557-1599</sub> was complexed with eIF4A or eIF4A&#8226;ATP, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="fig7" ref-type="fig">Fig. 7</xref><italic toggle="yes">D</italic>), representing a &#8764;2-fold increase in binding affinity. This pattern likely suggests that for ApppG-capped mRNAs, both eIF4E&#8226;4E-BP1 and eIF4GI<sub>557-1599</sub> can interact with mRNA simultaneously, resulting in tighter binding. Hence, for both m<sup>7</sup>G- and ApppG-capped mRNAs, eIF4GI<sub>557-1599</sub> retains the ability to bind directly to the mRNA.<fig id="fig7" position="float" orientation="portrait"><label>Figure 7</label><caption><p><bold>Fluorescence anisotropy analyses of eIF4GI<sub>557-1599</sub> (alone or in complex with eIF4A</bold> &#177; <bold>ATP) binding to ApppG-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, and p53<sub>B</sub> encoding mRNAs either alone or as part of the mRNA</bold>&#8226;<bold>eIF4E</bold>&#8226;<bold>4E-BP1 ternary complex</bold>. Normalized anisotropy changes (denoted as r&#772;) for the interaction of eIF4GI<sub>557-1599</sub> binding to mRNAs alone (-&#9642;-) and mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx11.gif"/>); eIF4GI<sub>557-1599</sub>&#8226;eIF4A binding to mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx12.gif"/>), and eIF4GI<sub>557-1599</sub>&#8226;eIF4A&#8226;ATP to mRNA&#8226;eIF4E&#8226;4E-BP1 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx13.gif"/>) with 10 nM ApppG-capped 5&#8242;UTR of (<italic toggle="yes">A</italic>) HIF-1&#945;, (<italic toggle="yes">B</italic>) p53<sub>A</sub>, (<italic toggle="yes">C</italic>) FGF-9 and (<italic toggle="yes">D</italic>) p53<sub>B</sub> encoding mRNA transcripts fluorescein-labeled at 3&#8242;terminus, respectively. Data points corresponding to the average from three independent anisotropy measurements were normalized and plotted against protein concentration (&#956; M). Curves represent Hill-equation fits, as described in materials and methods, used to calculate the corresponding K<sub>D</sub> values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr7.jpg"/></fig></p></sec><sec id="sec1.7"><title>eIF4GI<sub>557-1599</sub> does not bind the eIF4E&#8226;4E-BP1 complex, suggesting mRNA-mediated recruitment</title><p id="p0095">It was expected that eIF4GI<sub>557-1599</sub> would not bind to the eIF4E&#8226;4E-BP1 complex because 4E-BP1 blocks the eIF4GI<sub>557-1599</sub> binding site. To test this assumption, fluorescence anisotropy assays were performed with a fluorescein-labeled 4E-BP1 peptide (residues PGGTRIIYDRKFLMECRNSP, with Fluorescein isothiocyanate (FITC) conjugated at the Lys residue) in the absence of mRNA, thereby distinguishing direct protein&#8211;protein interactions from mRNA-mediated binding. This 20-residue sequence includes the canonical eIF4E-binding motif and has been widely used to recapitulate the binding affinity of full-length 4E-BP1 in biochemical studies (<xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib72" ref-type="bibr">72</xref>). Titration of eIF4E into FITC&#8211;4E-BP1 peptide resulted in a marked increase in anisotropy with a K<sub>D</sub> value of (5 &#177; 3.7) nM (<xref rid="appsec1" ref-type="sec">Fig. S6</xref>), consistent with the high-affinity binding between eIF4E and the 4E-BP1 peptide (<xref rid="bib73" ref-type="bibr">73</xref>). Note that, due to detection limits, there is a huge degree of uncertainty in the K<sub>D</sub> values below 10 nM. In contrast, titration of eIF4GI<sub>557-1599</sub> into either the free FITC&#8211;4E-BP1 peptide or the pre-formed FITC&#8211;4E-BP1&#8226;eIF4E showed negligible changes in anisotropy (<xref rid="appsec1" ref-type="sec">Fig. S6</xref>). These results indicated that eIF4GI<sub>557-1599</sub> does not bind to the 4E-BP1 peptide or eIF4E&#8226;4E-BP1 in the absence of mRNA (<xref rid="appsec1" ref-type="sec">Fig. S6</xref>), indicating that any eIF4GI<sub>557-1599</sub> binding observed in mRNA-based assays (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>, <xref rid="fig6" ref-type="fig">Fig. 6</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>, and <xref rid="fig7" ref-type="fig">7</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">D</italic>) reflects mRNA-dependent interactions rather than direct protein-protein interaction with eIF4E&#8226;4E-BP1. eIF4GI<sub>557-1599</sub> likely binds directly with internal or structural elements within the 5&#8242;UTRs, potentially stabilized in the mRNA&#8226;eIF4E&#8226;4E-BP1 complex, aligning with previous reports that direct eIF4GI<sub>557-1599</sub>-mRNA interactions facilitate translation under conditions where cap-dependent translation is impaired (<xref rid="bib38" ref-type="bibr">38</xref>).</p></sec><sec id="sec1.8"><title>eIF4GI<sub>557-1599</sub> cannot displace the FITC-labeled 4E-BP1 peptide from the eIF4E&#8211;mRNA complex</title><p id="p0100">To examine the extent to which eIF4GI<sub>557-1599</sub> can displace 4E-BP1 from the eIF4E&#8226;4E-BP1, fluorescence anisotropy assays were performed using a FITC-labeled 4E-BP1 peptide pre-bound to eIF4E in the presence of various capped mRNAs. Increasing concentrations of eIF4GI<sub>557-1599</sub> were titrated into pre-formed eIF4E&#8226;4E-BP1-FITC-peptide containing either m<sup>7</sup>G-capped or ApppG-capped 5&#8242;UTRs of HIF-1&#945;, p53<sub>A</sub>, FGF-9, or p53<sub>B</sub> encoding mRNAs. Displacement of the labeled 4E-BP1 peptide by eIF4GI<sub>557-1599</sub> would be expected to result in a decrease in anisotropy due to 4E-BP1 peptide dissociation, whereas simultaneous binding would be expected to increase anisotropy. Across all tested mRNAs, anisotropy consistently increased with eIF4GI<sub>557-1599</sub> titration, indicating that eIF4GI<sub>557-1599</sub> does not displace 4E-BP1 from eIF4E&#8226;4E-BP1, and that the observed binding in mRNA-based assays possibly arises from eIF4GI<sub>557-1599</sub> interacting directly with mRNA rather than competing for the eIF4E-binding site. Importantly, this effect was independent of the cap structure, as similar K<sub>D</sub> values were observed for m<sup>7</sup>G- and ApppG-capped mRNAs. For example, K<sub>D</sub> values for eIF4GI<sub>557-1599</sub> binding were (21 &#177; 0.7) nM vs. (30 &#177; 3.1) nM for the 5&#8242;UTR of HIF-1&#945;, (29 &#177; 1.3) nM vs. (35 &#177; 1.5) nM for the 5&#8242;UTR of p53<sub>A</sub>, (32 &#177; 0.3) nM vs. (25 &#177; 1.0) nM for the 5&#8242;UTR of FGF-9, (47 &#177; 0.7) nM vs. (42 &#177; 0.7) nM for the 5&#8242;UTR of p53<sub>B</sub> mRNAs, respectively (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>, <xref rid="fig8" ref-type="fig">Fig. 8</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>), comparing m<sup>7</sup>G- and ApppG-capped mRNA transcripts. Thus, eIF4GI<sub>557-1599</sub> binding in these assays reflects direct interaction with the mRNA, potentially stabilized by structural features or conformational changes in the mRNA&#8226;eIF4E&#8226;4E-BP1 complex rather than displacement of 4E-BP1.<fig id="fig8" position="float" orientation="portrait"><label>Figure 8</label><caption><p><bold>Fluorescence anisotropy analyses of eIF4GI<sub>557-1599</sub> binding to mRNA&#8226;eIF4E&#8226;4E-BP1-FITC-Peptide ternary complex</bold>. Normalized anisotropy changes (denoted as r&#772;) for the interaction of eIF4GI<sub>557-1599</sub> binding to pre-assembled mRNA&#8226;eIF4E&#8226;4E-BP1-FITC-peptide ternary complexes in the presence of different 5&#8242;capped mRNAs. Each mRNA was tested in both m<sup>7</sup>G-capped (<italic toggle="yes">A</italic>) and ApppG-capped (<italic toggle="yes">B</italic>) forms. 5&#8242;UTRs of mRNA encoding HIF-1&#945; (-&#9642;-), p53<sub>A</sub> (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx11.gif"/>), FGF-9 (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx12.gif"/>), and p53<sub>B</sub> (<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fx13.gif"/>) were analyzed. All assays were performed using 20 nM fluorescein-labeled 4E-BP1 peptide. Data points corresponding to the average from three independent anisotropy measurements were normalized and plotted as a function of eIF4GI<sub>557-1599</sub> concentration (&#956; M). Curves represent Hill-equation fits, as deciphered in materials and methods, used to calculate the corresponding K<sub>D</sub> values.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr8.jpg"/></fig></p></sec></sec><sec id="sec2"><title>Discussion</title><p id="p0105">In this study, fluorescence-based steady state anisotropy assays and <italic toggle="yes">in-vitro</italic> translation assays were used to explore the quantitative binding and mechanisms by which elevated 4E-BP1 levels influence eIF4E-independent translation of a subset of cellular mRNAs. Building on a previous finding that 5&#8242;end accessibility is essential for 43S PIC recruitment in CITE-like translation of HIF-1&#945;-UTR-Luc (<xref rid="bib16" ref-type="bibr">16</xref>), and p53<sub>A</sub>-UTR-Luc mRNAs, but dispensable for IRES-like FGF-9-UTR-Luc, or p53<sub>B</sub>-UTR-Luc mRNAs (<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib34" ref-type="bibr">34</xref>)&#8212;this study examined how 4E-BP1 modulates these distinct mechanisms and can have a differential effect on the translation of each subset of mRNAs.</p><p id="p0110">It was observed that the eIF4E&#8226;4E-BP1 bound both m<sup>7</sup>G-capped and ApppG-capped CITE-like (<italic toggle="yes">e</italic>.<italic toggle="yes">g</italic>., HIF-1&#945;-UTR and p53<sub>A</sub>-UTR) mRNAs with &#8764;4-5-fold higher binding affinities than eIF4E alone (<xref rid="fig1" ref-type="fig">Fig. 1</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, and <xref rid="fig2" ref-type="fig">2</xref>, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>), consistent with reports that eIF4E binds mRNA <italic toggle="yes">via</italic> enthalpy-driven interactions (<xref rid="bib74" ref-type="bibr">74</xref>), further stabilized by the conserved PGVTS/T motif of 4E-BP1 enhancing binding &#8764;1000-fold compared to eIF4E binding to cap analogs (<xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib74" ref-type="bibr">74</xref>, <xref rid="bib75" ref-type="bibr">75</xref>). Structural features such as stem-loops in CITE-like mRNAs (<xref rid="bib43" ref-type="bibr">43</xref>) may contribute to this regulatory mechanism, particularly under stress, where stabilized eIF4E&#8226;4E-BP1 may shift translation from cap-dependent to eIF4E-independent, selectively promoting translation of mRNAs crucial for cellular adaptation and survival. The observed transcript-specific modulation&#8212;where eIF4E&#8226;4E-BP1 exhibits stronger binding to CITE-like than IRES-like mRNAs&#8212;suggests that 4E-BP1 selectively represses or permits translation based on 5&#8242;UTR architecture (<xref rid="bib16" ref-type="bibr">16</xref>).</p><p id="p0115"><italic toggle="yes">In vitro</italic> translation assays showed that elevated 4E-BP1 significantly inhibited the translation of CITE-like (HIF-1&#945;, and p53<sub>A</sub>-UTR-Luc) mRNA transcripts, while minimally affecting IRES-like (FGF-9, and p53<sub>B</sub>-UTR-Luc) mRNAs (<xref rid="fig3" ref-type="fig">Fig. 3</xref>, <italic toggle="yes">C</italic>&#8211;<italic toggle="yes">F</italic>) although both CITE- and IRES-like mRNA constructs bound eIF4E&#8226;4E-BP1 with high affinity. This inhibition corelated with a &#8764;4-5-fold higher binding affinity of eIF4E&#8226;4E-BP1 compared to eIF4E alone for CITE-like mRNAs, likely reflecting restricted 43S PIC access to the 5&#8242;end. The effect observed for both functional m<sup>7</sup>G- and non-functional ApppG-capped transcripts indicates that the underlying mechanism depends primarily on 5&#8242;UTR structure rather than cap identity.</p><p id="p0120">In contrast, the modest (&#8764;2-fold) increase in eIF4E&#8226;4E-BP1 binding to IRES-like mRNAs had little impact on their translation, even at high 4E-BP1 levels (<xref rid="fig3" ref-type="fig">Fig. 3</xref>, <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>). These results are consistent with earlier observations that 5&#8242;end hairpins do not impair translation of ApppG-capped FGF-9-UTR-Luc, and p53<sub>B</sub>-UTR-Luc mRNAs (<xref rid="bib34" ref-type="bibr">34</xref>). This supports a model in which these mRNAs recruit ribosomes internally, independent of 5&#8242;end accessibility or eIF4E binding (<xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib57" ref-type="bibr">57</xref>), resembling viral and cellular IRES-containing mRNAs that translate independently of the 5&#8242;cap (<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib76" ref-type="bibr">76</xref>, <xref rid="bib77" ref-type="bibr">77</xref>, <xref rid="bib78" ref-type="bibr">78</xref>). The modest increase in eIF4E&#8226;4E-BP1 binding likely reflects the distal binding of eIF4GI<sub>557-1599</sub> or the 43S PIC from the 5&#8242;cap (<xref rid="bib34" ref-type="bibr">34</xref>), making tighter eIF4E&#8226;4E-BP1 binding irrelevant. Consequently, these mRNAs are efficiently translated in the presence of 4E-BP1 through direct ribosome recruitment by eIF4GI<sub>557-1599</sub> (<xref rid="bib79" ref-type="bibr">79</xref>)&#8212;a strategy commonly exploited by viruses to evade 4E-BP1-mediated translational inhibition (<xref rid="bib80" ref-type="bibr">80</xref>). The efficiency of this mechanism can vary with cellular stress, 4E-BP1 phosphorylation, and eIF availability (<xref rid="bib81" ref-type="bibr">81</xref>, <xref rid="bib82" ref-type="bibr">82</xref>, <xref rid="bib83" ref-type="bibr">83</xref>). Overall, IRES-like mRNAs promote translation without 5&#8242;end scanning, facilitating ribosomal recruitment despite 4E-BP1 inhibition (<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib65" ref-type="bibr">65</xref>, <xref rid="bib84" ref-type="bibr">84</xref>). In this context, 4E-BP1 has been shown to drive translational reprogramming under stress, promoting cap-independent translation (<xref rid="bib44" ref-type="bibr">44</xref>, <xref rid="bib85" ref-type="bibr">85</xref>, <xref rid="bib86" ref-type="bibr">86</xref>). Collectively, these findings suggest that 5&#8242;UTR architecture, rather than cap identity, dictates mRNA sensitivity to 4E-BP1. This observation raises the possibility that transcripts such as HIF-1&#945;&#8212;previously classified as IRES-driven (<xref rid="bib94" ref-type="bibr">94</xref>)&#8212;may instead function through a CITE-like mechanism (<xref rid="bib36" ref-type="bibr">36</xref>, <xref rid="bib95" ref-type="bibr">95</xref>), underscoring the need to refine mRNA translational classification based on structural and functional features.</p><p id="p0125">To examine adaptive translation under elevated 4E-BP1, we assessed the effects of eIF4E and eIF4GI<sub>557&#8211;1599</sub>&#8226;eIF4A on CITE-like and IRES-like mRNAs. Under elevated 4E-BP1, eIF4GI<sub>557&#8211;1599</sub>&#8226;eIF4A effectively alleviated much of the translational repression of CITE-like mRNAs, but not the modest inhibition of IRES-like ones (<xref rid="fig5" ref-type="fig">Fig. 5</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">H</italic>). This suggests that recruitment of the eIF4GI<sub>557&#8211;1599</sub> scaffold with eIF4A helicase&#8212;can substitute for impaired eIF4E function by promoting 43S PIC loading near the 5&#8242;end. Consistent with this, eIF4GI<sub>557&#8211;1599</sub> alone also exhibited a similar trend toward restoring CITE-like mRNA translation (data not included). Such eIF4GI<sub>557&#8211;1599</sub>-dependent, eIF4E-independent initiation has been reported for several stress-responsive mRNAs, including 53BP1, HIF-1&#945;, p53, BRCA1, and GADD45a (<xref rid="bib87" ref-type="bibr">87</xref>). Elevated eIF4GI<sub>557-1599</sub> levels may enhance ribosome&#8211;mRNA interactions or stabilize initiation at the 5&#8242;end (<xref rid="bib88" ref-type="bibr">88</xref>, <xref rid="bib89" ref-type="bibr">89</xref>, <xref rid="bib90" ref-type="bibr">90</xref>), thereby reducing cap dependency and conferring resistance to 4E-BP1-mediated inhibition (<xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib91" ref-type="bibr">91</xref>, <xref rid="bib92" ref-type="bibr">92</xref>).</p><p id="p0130">Increasing eIF4E levels under high 4E-BP1 conditions also partially restored CITE-like mRNA translation, likely by re-establishing functional eIF4F complexes that outcompete 4E-BP1 for eIF4E binding. In contrast, addition of eIF4E had modest effect on IRES-like mRNAs (<xref rid="fig4" ref-type="fig">Fig. 4</xref>, <italic toggle="yes">A</italic>&#8211;<italic toggle="yes">H</italic>), underscoring their differential reliance on cap-dependent initiation. This agrees with studies indicating that eIF4E promotes translation of highly structured, growth-promoting mRNAs linked to cellular transformation and tumor progression (<xref rid="bib93" ref-type="bibr">93</xref>, <xref rid="bib94" ref-type="bibr">94</xref>).</p><p id="p0135">Overall, these findings lead to the model illustrated in <xref rid="fig9" ref-type="fig">Figure 9</xref>: eIF4E&#8226;4E-BP1 binds tightly to canonical cap-dependent mRNA and inhibits translation by preventing preinitiation complex recruitment. CITE-like mRNAs are similarly inhibited by eIF4E&#8226;4E-BP1; however, this inhibition can be alleviated through overexpression of eIF4GI<sub>557-1599</sub>, which restores translation&#8212;unlike in the canonical cap-dependent context. IRES-like mRNAs, while binding eIF4E&#8226;4E-BP1 relatively tightly, are minimally affected by eIF4E&#8226;4E-BP1. Taken together, these findings suggest a synergistic interaction of 4E-BP1 and eIF4GI<sub>557-1599</sub> in selective modulation of protein synthesis. This model highlights how 4E-BP1 and eIF4GI<sub>557-1599</sub> differentially regulate both cap-dependent and cap-independent translation of CITE-like and IRES-like mRNAs. Such selective modulation of mRNA translation under stress conditions lays the groundwork for therapeutic approaches targeting translation in stress-related diseases.<fig id="fig9" position="float" orientation="portrait"><label>Figure 9</label><caption><p><bold>Proposed model illustrating the differential effects of 4E-BP1 and eIF4GI<sub>557-1599</sub> on cap-independent translation of CITE-like and IRES-like mRNAs</bold>. Under normal conditions, a pool of mRNAs&#8212;including canonical cap-dependent, CITE-like, and IRES-like transcripts&#8212;is available for translation. Overexpression of 4E-BP1, such as under stress conditions, promotes sequestration of eIF4E. The resulting eIF4E&#8226;4E-BP1 binds to the m<sup>7</sup>G-cap of these mRNAs, blocking 43S PIC recruitment at the 5&#8242; m<sup>7</sup>G-cap and inhibiting translation of canonical cap-dependent and CITE-like mRNAs, while IRES-like mRNAs remain minimally affected. Subsequent overexpression of eIF4GI<sub>557-1599</sub> enhances its availability to interact with mRNAs. eIF4GI<sub>557-1599</sub> restores translation inhibition of CITE-like mRNAs, likely by directly interacting with the structured 5&#8242;UTRs but fails to rescue translation of cap-dependent mRNAs and has limited impact on IRES-like mRNAs whose translation is inherently resistant to 4E-BP1-mediated translation repression. CITE, cap-independent translation enhancer; eIF, eukaryotic initiation factor; IRES, internal ribosome entry site; m<sup>7</sup>G, methyl guanosine; PIC, preinitiation complex.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr9.jpg"/></fig></p></sec><sec id="sec3"><title>Experimental procedures</title><sec id="sec3.1"><title>Purification of recombinants eIF4GI<sub>557-1599</sub>, eIF4E, 4E-BP1, 4E-BP1 mutant (4E-BP1-4Ala), and eIF4A</title><p id="p0140">The plasmids encoding human eIF4GI<sub>557-1599</sub> with an N-terminal 6x-histidine tag and a TEV protease cleavage site was a generous gift from Dr Christopher S. Fraser. The human 4E-BP1 coding sequence (GenBank: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="NCBI:nucleotide" xlink:href="BC058073.1" id="intref0010">BC058073.1</ext-link>) was obtained from the NCBI protein database. A dominant-negative mutant, 4E-BP1-4Ala (T37 A, T46 A, S65 A, T70 A), was designed by mutating key phosphorylation sites to alanine (<xref rid="bib61" ref-type="bibr">61</xref>). The corresponding nucleotide sequences of wild-type 4E-BP1 and 4E-BP1-4Ala were subcloned into the NdeI and XhoI sites of a modified pET28a-TEV expression vector, incorporating an N-terminal 6 &#215; histidine tag. The wild-type 4E-BP1 plasmid was obtained from GenScript, while the 4E-BP1-4Ala plasmid was purchased from AddGene. Plasmid encoding eIF4GI<sub>557-1599</sub>, eIF4E, 4E-BP1 and 4E-BP1-4Ala were transformed into <italic toggle="yes">Escherichia coli</italic> BL21 (DE3) competent cells following the New England Biolabs transformation protocol for protein expression. <xref rid="appsec1" ref-type="sec">Figure S7</xref> illustrates the domain organization of the proteins analyzed in this study.</p><p id="p0145">All these proteins were recombinantly expressed in E.coli BL21CodonPlus (DE3)-RIL cells (Agilent). 4E-BP1 and 4E-BP1-4Ala was purified from bacterial cell lysates using Ni<sup>2+</sup>-nitrilotri-acetic acid (Ni-NTA) affinity (GE HealthCare Life Sciences) and HisPur Ni-NTA spin column (Thermo Fisher Scientific), as per the manufacturer&#8217;s instructions (<xref rid="bib34" ref-type="bibr">34</xref>). eIF4GI<sub>557-1599</sub>, was purified using a combination of nickel-nitrilotriacetic acid (Ni-NTA) affinity followed by heparin affinity columns, as previously described (<xref rid="bib34" ref-type="bibr">34</xref>). The eIF4A clone contained an N-terminal His&#8211;MBP fusion tag followed by a TEV protease cleavage site. eIF4A was expressed in <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> BL21 (DE3) cells and purified by Ni&#8211;NTA affinity chromatography, followed by TEV cleavage and buffer exchange, as described previously (<xref rid="bib24" ref-type="bibr">24</xref>). The purified 6x-histidine tagged proteins were dialyzed overnight against storage buffer (20 mM HEPES&#8211;KOH pH 7.6, 200 mM KCl, 10 mM &#946;-mercaptoethanol, and 10% glycerol) in the presence of tobacco etch virus (TEV) protease to cleave off the tags (<xref rid="bib95" ref-type="bibr">95</xref>). The untagged proteins were further purified and concentrated using 1 ml HiTrap Heparin HP columns (GE HealthCare Life Sciences) (<xref rid="bib34" ref-type="bibr">34</xref>). The eluted proteins were analyzed on 10% SDS-PAGE gels, and pure fractions (&gt;95% purity) were pooled and dialyzed overnight against storage buffer. For visual confirmation and analysis of protein purity, samples were run on SDS-PAGE and stained with Coomassie Brilliant Blue (Thermo Fisher Scientific). (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib74" ref-type="bibr">74</xref>). Aliquots were then stored at &#8722;80 &#176;C. Proteins were then concentrated, and their concentrations were quantified using Bradford assay (standard curve method). 4E-BP1, and 4E-BP1-4Ala were analyzed using a 10% SDS-PAGE gel.</p><p id="p0150">The human eIF4E clone was also a kind gift from Prof. Christopher S. Fraser (UC Davis). This eIF4E construct had an N-terminal polyhistidine tag, with a TEV protease cleavage site between the histidine tag and eIF4E. For expression of recombinant eIF4E protein, <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> Rosetta (DE3) was transformed with this clone and bacterial cells from 1.5 L of LB medium were used. The bacterial cells were grown at 37&#176;C till the A<sub>600</sub> reached 0.6 to 0.8. Protein expression was induced overnight at 20&#176;C, by adding IPTG (final concentration of 0.5 mM). The cells were pelleted and sonicated in the lysis buffer (25 mM HEPES, pH 7.5, 300 mM KCl, 10% glycerol, 1 mM DTT, 20 mM imidazole, and protease inhibitor tablet). The supernatant was filtered through a 400-micron syringe filter and loaded on a pre-equilibrated 5 ml Ni-NTA column (pre-equilibrated with the lysis buffer). The column was washed with 20 ml buffer E (25 mM HEPES, pH 7.5, 300 mM KCl, 10% glycerol, 1 mM DTT, and 50 mM imidazole), and the protein was eluted with buffer E containing 500 mM imidazole. Fractions containing eIF4E were pooled and dialyzed overnight against buffer E (without any imidazole) containing TEV protease, at 4 &#176;C. The dialyzed samples were further purified on a 5 ml Q-Sepharose column to separate the untagged protein from the cleaved tag and the TEV protease. The KCl concentration of dialyzed samples was adjusted to 100 mM, and the sample was loaded onto a 5 ml preequilibrated Q-Sepharose column (preequilibrated with buffer A 25 mM HEPES pH 7.5, 100 mM KCl, 10% glycerol, and 1 mM DTT). The proteins were eluted using a step gradient of 150 to 500 mM KCl in buffer A. Fractions containing eIF4E, were pooled, concentrated, and stored at &#8722;80 &#176;C. The protein concentrations were quantified using the Bradford&#8217;s assay and purity was assessed by 10% SDS-PAGE gel (<xref rid="appsec1" ref-type="sec">Fig. S8</xref>).</p></sec><sec id="sec3.2"><title>Preparation of mRNAs for fluorescence anisotropy-based equilibrium binding studies</title><p id="p0155">DNA templates corresponding to the 5&#8242;UTRs of mRNAs encoding HIF-1&#945; (294 nucleotides [nt]; GenBank accession no. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=AH006957.2" id="intref0015">AH006957.2</ext-link>), FGF-9 (177 nt; GenBank accession no. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=AY682094.1" id="intref0020">AY682094.1</ext-link>), one isoform of p53 (p53<sub>A</sub>) (136 nt; GenBank accession no. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=JN900492.1" id="intref0025">JN900492.1</ext-link>), the 5&#8242;UTR for a second isoform of p53 (p53<sub>B</sub>) (117 nt; GenBank accession no. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=MG595994.1" id="intref0030">MG595994.1</ext-link>), and &#946;-actin (84 nt; GenBank accession no. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=AK301372.1" id="intref0035">AK301372.1</ext-link>), respectively (<xref rid="appsec1" ref-type="sec">Table S1</xref>) were purchased from Integrated DNA Technologies, and the corresponding mRNAs were synthesized <italic toggle="yes">via in-vitro</italic> transcription using the HiScribe T7 Quick High Yield RNA Synthesis Kit (New England Biolabs Inc) following the manufacturer&#8217;s protocol (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib74" ref-type="bibr">74</xref>). The purified mRNAs were then labeled at the 3&#8242; termini in an oxidation reaction using a final concentration of 30 mM mRNA,105 mM of NaOAc pH-5.2, and 15 mM of sodium periodate. The reaction tube was covered with aluminum foil and incubated for 30 min in the dark (<xref rid="bib34" ref-type="bibr">34</xref>, <xref rid="bib74" ref-type="bibr">74</xref>). After incubation, 1 M sodium sulfite was added and incubated for an additional 10 min in the dark. The oxidation product was purified using ethanol precipitation. The purified oxidized mRNA was then used for a labeling reaction by adding a final concentration of 1 mM flouroscein-5-thiosemicarbazide (FITC) and 50 mM Na-phosphate buffer pH 6.5 (<xref rid="bib34" ref-type="bibr">34</xref>). The reaction was covered with aluminum foil and incubated in the dark for 2 h. Following this incubation period, 1 M NaCNBH<sub>3</sub> was added, and the reaction was further incubated overnight at 4 &#176;C. After overnight incubation, the labeled product was purified using a two-step purification. Ethanol precipitation followed using the mRNA Clean and Concentrator Kit from Zymo Research following the manufacturer&#8217;s protocol (<xref rid="bib34" ref-type="bibr">34</xref>). The purified and labeled mRNAs were then capped with Ribo m<sup>7</sup>G Cap Analog (Promega), catalog number P1802, using the vaccinia capping system, catalog number M2080S from New England Biolabs. For the ApppG capped analog, G(5&#8242;)ppp(5&#8242;)A RNA Cap structure Analog (New England Biolabs Inc) was used. These RNAs were synthesized using Co-transcriptional capping using the HiScribe T7 Quick High Yield RNA Synthesis Kit. Briefly, 5&#8242;end of the mRNAs was capped, 3&#8242;termini were labeled with FITC, and purified following previously discussed protocol (<xref rid="bib34" ref-type="bibr">34</xref>). The mRNA concentrations were determined using nano-drop UV-visible spectrometer and integrity was verified by 1.5% agarose gel electrophoresis (<xref rid="bib34" ref-type="bibr">34</xref>).</p></sec><sec id="sec3.3"><title>Binding assay using fluorescence anisotropy</title><p id="p0160">Fluorescein isothiocyanate (FITC) (Sigma Aldrich) labeled mRNAs (FGF-9, HIF-1&#945;, p53<sub>A</sub>, p53<sub>B</sub>) were diluted to 10 nM in binding buffer (20 mM HEPES-KOH, pH 7.5, 200 mM KCl, and 1 mM MgCl<sub>2</sub>). Fluorescence anisotropy experiments were performed to assess the binding of 3&#8242; labeled 5&#8242;UTR of mRNAs encoding FGF-9, HIF-1&#945;, and two isoforms of p53 (p53<sub>A</sub> and p53<sub>B</sub>) with eIF4E, eIF4E in absence and presence of 4E-BP1, and 4E-BP1 alone. Binding experiments were carried out using the equilibrium titration module of an SF-300X stopped-flow fluorimeter (KinTek Corporation) and a temperature controller (Fisher Scientific). Fluorescein-labeled RNAs were excited at 495 nm and resulting emission was detected at 515 nm using blocking edge BrightLine long pass filter (Semrock Inc.). For each assay, 200 &#956;l of 10 nM of fluorescein-labeled mRNA was loaded into the cuvette and titrated by automated continuous injection of 20 &#956;l of varying concentrations of proteins or protein complexes over a period of 20 min at 25 &#176;C.</p><p id="p0165">To assess mRNA binding, 10 nM mRNA was incubated either alone or after preassembly with 0.5 &#956;M eIF4E and 1 &#956;M 4E-BP1 (1:2) for 20 min. Titrations were then performed with 2.5 &#956;M eIF4GI<sub>557-1599</sub> (alone or in complex with eIF4A/ATP). To assess peptide binding, a FITC-labeled 4E-BP1 peptide (sequence: PGGTRIIY[K(FITC)]DRFLMECRNSP; &#8805;98% purity; GenScript) was used at 20 nM. The peptide was tested either free in solution or after preincubation with 10 nM eIF4E for 20 min at 25 &#176;C. Where indicated, 4E-BP1-peptide&#8226;eIF4E complex was further incubated with 10 nM mRNA to form a ternary mRNA&#8226;eIF4E&#8226;4E-BP1-peptide complex prior to titration with eIF4GI<sub>557-1599</sub>. Direct eIF4E&#8211;4E-BP1 peptide interactions were measured by titrating 200 &#956;l of 20 nM peptide with 2.5 &#956;M eIF4E. 50 data points were collected for each anisotropy measurement. Data from three independent binding assays were averaged and used to calculate dissociation equilibrium constants (K<sub>D</sub>). The K<sub>D</sub> values were calculated by fitting the Hill equation using Origin Pro8 software (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.originlab.com/demodownload.aspx" id="intref0040">https://www.originlab.com/demodownload.aspx</ext-link>),<disp-formula id="ufd1"><mml:math id="M1" altimg="si1.svg"><mml:mrow><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mtext>obs</mml:mtext></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mi>min</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mi>max</mml:mi></mml:msub><mml:mo linebreak="badbreak">&#8722;</mml:mo><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mi>min</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mtext>Protein</mml:mtext><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">D</mml:mi></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mtext>Protein</mml:mtext><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where r<sub>obs</sub> is the observed anisotropy value, r<sub>min</sub> is the minimum anisotropy value in the absence of protein (4E-BP1), r<sub>max</sub> is the final saturated anisotropy value, [Protein] is the concentration of eIF4E&#8226;4E-BP1 complex and K<sub>D</sub> is the equilibrium dissociation constant. The chi-squared values (&#967;<sup>2</sup>) that represented the statistical goodness of fit were always close to 1 (<xref rid="tbl1" ref-type="table">Tables 1</xref> and <xref rid="tbl2" ref-type="table">2</xref>). Fitting data to a two-site model did not improve the fit as judged by (&#967;<sup>2</sup>) values.</p></sec><sec id="sec3.4"><title>Preparation of the UTR-Luc reporter mRNAs for <italic toggle="yes">in-vitro</italic> translation assays</title><p id="p0170">The UTR-Luciferase mRNA constructs for the luciferase gene expression reporter assay were generated from the glycerol stocks gifted by Dr Solomon Haizel. The plasmids were cultured with ampicillin, purified with QIAprep Spin miniprep kit (Qiagen) following the manufacturer&#8217;s protocol, then linearized using Acc65I (ThermoScientific) and purified using the GeneJET gel extraction and DNA cleanup micro kit per manufacturer&#8217;s instructions (<xref rid="bib34" ref-type="bibr">34</xref>). DNA templates were <italic toggle="yes">in -vitro</italic> transcribed using a T7 RiboMax large-scale RNA production kit (Promega) following the manufacturer&#8217;s protocol. ApppG (NEB) or Ribo m<sup>7</sup>GpppA cap analog (Promega) were added to the transcription mix in an ApppG or Ribo m<sup>7</sup>GpppA:GTP ratio of 10:1 to get mRNA transcripts with non-functional and functional caps, respectively. Capped mRNAs were poly(A) tailed using the poly(A) tailing kit (Invitrogen) following the manufacturer&#8217;s protocol. The resulting capped and polyadenylated mRNAs were then purified using a Monarch RNA Cleanup kit, 50 &#956;g (<italic toggle="yes">New England Biolabs</italic>) following the manufacturer&#8217;s protocol. RNA concentrations were determined using a Nano-drop UV-visible spectrometer.</p></sec><sec id="sec3.5"><title>Luciferase-based gene expression reporter assays</title><p id="p0175"><italic toggle="yes">In vitro</italic> translation assays were performed by adding 1 &#956;g of UTR-Luc mRNAs to 25 &#956;l <italic toggle="yes">in-vitro</italic> reaction mixtures made using the Rabbit Reticulocyte Lysate (RRL) <italic toggle="yes">in-vitro</italic> translation system from Promega. The reaction mixtures contained 70% (v/v) RRL (Promega), 1 mM amino acid mixture (Promega), 75 mM KCl (Fisher Chemical), 0.5 mM MgCl<sub>2</sub> (Invitrogen) and 10 units/&#956;l RiboLock RNase inhibitor (ThermoScientific) (<xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib34" ref-type="bibr">34</xref>). First, proteins were incubated with lysate mixture for 10 min at 30 &#176;C in the absence of mRNA (<xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib65" ref-type="bibr">65</xref>). Then 1 &#956;g (60 nM) of UTR-Luc mRNA was added to the RRL mixtures, incubated at 30 &#176;C for 40 min and the reaction was stopped by placing the tubes in ice for 10 min 5 &#956;l of each reaction mixture was added to 40 &#956;l Bright-Glo luciferase assay reagent (Promega) and measured for luminescence using a SpectraMax iD5 microplate reader (Molecular Devices) with default endpoint luminescence settings. Each reaction was measured in triplicate using 3 different batches of RRLs and analyzed using GraphPad Prism 8. Statistical significance between the mean values were analyzed using two-tailed unpaired student&#8217;s <italic toggle="yes">t</italic> test (GraphPad Prism 8 software) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.graphpad.com/" id="intref0045">https://www.graphpad.com/</ext-link>). The statistical significance was set at <italic toggle="yes">p</italic> &lt; 0.05 and the <italic toggle="yes">p</italic>-values were calculated. The calculated <italic toggle="yes">p</italic>-values for the analyses are indicated as follows on the brackets above the bar graphs (Figs. n.s (non-significant), <italic toggle="yes">p</italic> = 0.12; &#8727;, <italic toggle="yes">p</italic> = 0.033; &#8727;&#8727;, <italic toggle="yes">p</italic> = 0.002; &#8727;&#8727;&#8727;, <italic toggle="yes">p</italic> &lt; 0.001).</p></sec></sec><sec sec-type="data-availability" id="sec4"><title>Data availability</title><p id="p0180">All data are contained in the manuscript. This manuscript contains <xref rid="appsec1" ref-type="sec">supporting information</xref>.</p></sec><sec sec-type="supplementary-material" id="sec5"><title>Supporting information</title><p id="p0185">This article contains <xref rid="appsec1" ref-type="sec">supporting information</xref>.</p></sec><sec sec-type="COI-statement" id="coi0010"><title>Conflict of interest</title><p id="p0190">These authors declare they have no conflict of interest with the contents of this article.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>R.M.</given-names></name></person-group><article-title>Autoregulation of connexin43 gap junction formation by internally translated isoforms</article-title><source>Cell Rep.</source><volume>5</volume><year>2013</year><fpage>611</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">24210816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2013.10.009</pub-id><pub-id pub-id-type="pmcid">PMC3898934</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Raught</surname><given-names>B.G.A.</given-names></name></person-group><article-title>eIF4E activity is regulated at multiple levels</article-title><source>Int. J. Biochem. Cell Biol.</source><volume>31</volume><year>1999</year><fpage>43</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">10216943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1357-2725(98)00131-9</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Amorim</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Lach</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gkogkas</surname><given-names>C.G.</given-names></name></person-group><article-title>The role of the eukaryotic translation initiation factor 4E (eIF4E) in neuropsychiatric disorders</article-title><source>Front. Genet.</source><volume>9</volume><year>2018</year><fpage>561</fpage><pub-id pub-id-type="pmid">30532767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fgene.2018.00561</pub-id><pub-id pub-id-type="pmcid">PMC6265315</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Elia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Constantinou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>M.J.</given-names></name></person-group><article-title>Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1</article-title><source>Oncogene</source><volume>27</volume><year>2008</year><fpage>811</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">17653084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.onc.1210678</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Saltiel</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Blackshear</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>J.C.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway</article-title><source>J. Biol. Chem.</source><volume>270</volume><year>1995</year><fpage>18531</fpage><lpage>18538</lpage><pub-id pub-id-type="pmid">7629182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.270.31.18531</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Contu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Latronico</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rizzi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Catalucci</surname><given-names>D.</given-names></name><etal/></person-group><article-title>mTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice</article-title><source>J. Clin. Invest.</source><volume>120</volume><year>2010</year><fpage>2805</fpage><lpage>2816</lpage><pub-id pub-id-type="pmid">20644257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI43008</pub-id><pub-id pub-id-type="pmcid">PMC2912201</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Molinolo</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vitale-Cross</surname><given-names>L.</given-names></name><name name-style="western"><surname>Nohata</surname><given-names>N.</given-names></name><etal/></person-group><article-title>4E-BP1 is a tumor suppressor protein reactivated by mTOR inhibition in head and neck cancer</article-title><source>Cancer Res.</source><volume>79</volume><year>2019</year><fpage>1438</fpage><lpage>1450</lpage><pub-id pub-id-type="pmid">30894372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-18-1220</pub-id><pub-id pub-id-type="pmcid">PMC6445709</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sitzmann</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Dastidar</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Vu</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>C.E.</given-names></name><etal/></person-group><article-title>Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity</article-title><source>J. Clin. Invest.</source><volume>125</volume><year>2015</year><fpage>2952</fpage><lpage>2964</lpage><pub-id pub-id-type="pmid">26121750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI77361</pub-id><pub-id pub-id-type="pmcid">PMC4563739</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Bohm</surname><given-names>R.</given-names></name><name name-style="western"><surname>Imseng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Maier</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hiller</surname><given-names>S.</given-names></name></person-group><article-title>The dynamic mechanism of 4E-BP1 recognition and phosphorylation by mTORC1</article-title><source>Mol. Cell.</source><volume>81</volume><year>2021</year><fpage>2403</fpage><lpage>2416</lpage><pub-id pub-id-type="pmid">33852892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2021.03.031</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hinnebusch</surname><given-names>A.G.</given-names></name></person-group><article-title>Regulation of translation initiation in eukaryotes: mechanisms and biological targets</article-title><source>Cell</source><volume>136</volume><year>2009</year><fpage>731</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">19239892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2009.01.042</pub-id><pub-id pub-id-type="pmcid">PMC3610329</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Thakor</surname><given-names>N.</given-names></name><name name-style="western"><surname>Holcik</surname><given-names>M.</given-names></name></person-group><article-title>IRES-mediated translation of cellular messenger RNA operates in eIF2alpha- independent manner during stress</article-title><source>Nucleic Acids Res.</source><volume>40</volume><year>2012</year><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">21917851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkr701</pub-id><pub-id pub-id-type="pmcid">PMC3258125</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Spriggs</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Bushell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Willis</surname><given-names>A.E.</given-names></name></person-group><article-title>Internal ribosome entry segment-mediated translation during apoptosis: the role of IRES-trans-acting factors</article-title><source>Cell Death Differ.</source><volume>12</volume><year>2005</year><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">15900315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.cdd.4401642</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Komar</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Hatzoglou</surname><given-names>M.</given-names></name></person-group><article-title>Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states</article-title><source>Cell Cycle</source><volume>10</volume><year>2011</year><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">21220943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/cc.10.2.14472</pub-id><pub-id pub-id-type="pmcid">PMC3048795</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Spriggs</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Bushell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Willis</surname><given-names>A.E.</given-names></name></person-group><article-title>Translational regulation of gene expression during conditions of cell stress</article-title><source>Mol. Cell</source><volume>40</volume><year>2010</year><fpage>228</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">20965418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2010.09.028</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Velasquez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>P.S.</given-names></name></person-group><article-title>Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E)</article-title><source>J. Biol. Chem.</source><volume>294</volume><year>2019</year><fpage>11840</fpage><lpage>11852</lpage><pub-id pub-id-type="pmid">31201269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.RA119.008512</pub-id><pub-id pub-id-type="pmcid">PMC6682726</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name><name name-style="western"><surname>Terenin</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Smirnova</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Andreev</surname><given-names>D.E.</given-names></name></person-group><article-title>Cap-independent translation: what's in a name?</article-title><source>Trends Biochem. Sci.</source><volume>43</volume><year>2018</year><fpage>882</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">29789219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tibs.2018.04.011</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Ramirez-Valle</surname><given-names>F.</given-names></name><name name-style="western"><surname>Braunstein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zavadil</surname><given-names>J.</given-names></name><name name-style="western"><surname>Formenti</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>R.J.</given-names></name></person-group><article-title>eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy</article-title><source>J. Cell Biol.</source><volume>181</volume><year>2008</year><fpage>293</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">18426977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.200710215</pub-id><pub-id pub-id-type="pmcid">PMC2315676</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Ozreti&#263;</surname><given-names>P.B.</given-names></name><name name-style="western"><surname>Alessandra &amp; Inga</surname><given-names>A.</given-names></name><name name-style="western"><surname>Levanat</surname><given-names>S.</given-names></name></person-group><article-title>The growing relevance of cap-independent translation initiation in cancer-related genes</article-title><source>Periodicum Biologorum</source><volume>114</volume><year>2012</year><fpage>471</fpage><lpage>478</lpage></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name name-style="western"><surname>Gingras</surname><given-names>A.C.K.S.</given-names></name><name name-style="western"><surname>O'Leary</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hay</surname><given-names>N.</given-names></name></person-group><article-title>4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway</article-title><source>Genes Dev.</source><volume>12</volume><year>1998</year><fpage>502</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">9472019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.12.4.502</pub-id><pub-id pub-id-type="pmcid">PMC316523</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name name-style="western"><surname>Gingras AC</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Raught</surname><given-names>B.</given-names></name><name name-style="western"><surname>Polakiewicz</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Hoekstra</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Aebersold</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism</article-title><source>Genes Dev.</source><volume>13</volume><year>1999</year><fpage>1422</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">10364159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.13.11.1422</pub-id><pub-id pub-id-type="pmcid">PMC316780</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Hara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yonezawa</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kozlowski</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Sugimoto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Andrabi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Weng</surname><given-names>Q.P.</given-names></name><etal/></person-group><article-title>Regulation of eIF-4E-BP1 phosphorylation by mTOR</article-title><source>J. Biol. Chem.</source><volume>272</volume><year>1997</year><fpage>26457</fpage><lpage>26463</lpage><pub-id pub-id-type="pmid">9334222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.272.42.26457</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Peterson RT</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Hardwick</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>S.L.</given-names></name></person-group><article-title>Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12&#8211;rapamycinassociated protein</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>96</volume><year>1999</year><fpage>4438</fpage><lpage>4442</lpage><pub-id pub-id-type="pmid">10200280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.96.8.4438</pub-id><pub-id pub-id-type="pmcid">PMC16350</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>de la Parra</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ernlund</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alard</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruggles</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ueberheide</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>R.J.</given-names></name></person-group><article-title>A widespread alternate form of cap-dependent mRNA translation initiation</article-title><source>Nat. Commun.</source><volume>9</volume><year>2018</year><fpage>3068</fpage><pub-id pub-id-type="pmid">30076308</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05539-0</pub-id><pub-id pub-id-type="pmcid">PMC6076257</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>B.</given-names></name><name name-style="western"><surname>Haizel</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Goss</surname><given-names>D.J.</given-names></name></person-group><article-title>Mechanistic differences in eukaryotic initiation factor requirements for eIF4GI-driven cap-independent translation of structured mRNAs</article-title><source>J.Biol.Chem.</source><volume>300</volume><year>2024</year><object-id pub-id-type="publisher-id">107866</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbc.2024.107866</pub-id><pub-id pub-id-type="pmcid">PMC11570956</pub-id><pub-id pub-id-type="pmid">39384039</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name name-style="western"><surname>Braunstein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Karpisheva</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pola</surname><given-names>C.</given-names></name><name name-style="western"><surname>Goldberg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hochman</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yee</surname><given-names>H.</given-names></name><etal/></person-group><article-title>A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer</article-title><source>Mol. Cell.</source><volume>28</volume><year>2007</year><fpage>501</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">17996713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2007.10.019</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Meric-Bernstam</surname><given-names>F.C.H.</given-names></name><name name-style="western"><surname>Akcakanat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Do</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Lluch</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hennessy</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Hortobagyi</surname><given-names>G.N.</given-names></name><etal/></person-group><article-title>Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer</article-title><source>Breast Cancer Res.</source><volume>14</volume><year>2012</year><object-id pub-id-type="publisher-id">R138</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/bcr3343</pub-id><pub-id pub-id-type="pmcid">PMC4053117</pub-id><pub-id pub-id-type="pmid">23102376</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>Musa</surname><given-names>J.</given-names></name><name name-style="western"><surname>Orth</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Dallmayer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baldauf</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pardo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rotblat</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis</article-title><source>Oncogene</source><volume>35</volume><year>2016</year><fpage>4675</fpage><lpage>4688</lpage><pub-id pub-id-type="pmid">26829052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/onc.2015.515</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name name-style="western"><surname>She</surname><given-names>Q.B.</given-names></name><name name-style="western"><surname>Halilovic</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shirasawa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sasazuki</surname><given-names>T.</given-names></name><etal/></person-group><article-title>4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors</article-title><source>Cancer Cell</source><volume>18</volume><year>2010</year><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">20609351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccr.2010.05.023</pub-id><pub-id pub-id-type="pmcid">PMC3286650</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Elena Mart&#305;n</surname><given-names>M.</given-names></name><name name-style="western"><surname>Clara Redondo</surname><given-names>M.I.P.</given-names></name><name name-style="western"><surname>Isabel &#193;lvarez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salinas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fando</surname><given-names>J.L.</given-names></name></person-group><article-title>4E-binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers</article-title><source>Inter. J. Biochem. Cell Biol.</source><volume>32</volume><year>2000</year><fpage>6633</fpage><lpage>6642</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1357-2725(00)00007-8</pub-id><pub-id pub-id-type="pmid">10785360</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Salehi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mashayekhi</surname><given-names>F.</given-names></name></person-group><article-title>Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer</article-title><source>Clin. Biochem.</source><volume>39</volume><year>2006</year><fpage>404</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">16375881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinbiochem.2005.11.007</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name name-style="western"><surname>Seki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Takasu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sawada</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nakata</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>R.</given-names></name><name name-style="western"><surname>Segawa</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Prognostic significance of expression of eukaryotic initiation factor 4E and 4E-binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma</article-title><source>Lung Cancer</source><volume>70</volume><year>2010</year><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">20621385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lungcan.2010.03.006</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>L.J.B.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>D.F.</given-names></name><name name-style="western"><surname>Gumbleton</surname><given-names>M.</given-names></name></person-group><article-title>Phospho-4E-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma</article-title><source>Am. J. Cancer Res.</source><volume>5</volume><year>2015</year><fpage>2838</fpage><lpage>2848</lpage><pub-id pub-id-type="pmid">26609489</pub-id><pub-id pub-id-type="pmcid">PMC4633910</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Lacerda</surname><given-names>R.</given-names></name><name name-style="western"><surname>Menezes</surname><given-names>J.</given-names></name><name name-style="western"><surname>Romao</surname><given-names>L.</given-names></name></person-group><article-title>More than just scanning: the importance of cap-independent mRNA translation initiation for cellular stress response and cancer</article-title><source>Cell Mol. Life. Sci.</source><volume>74</volume><year>2017</year><fpage>1659</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">27913822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00018-016-2428-2</pub-id><pub-id pub-id-type="pmcid">PMC11107732</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Haizel</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Bhardwaj</surname><given-names>U.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>R.L.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Mitra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Goss</surname><given-names>D.J.</given-names></name></person-group><article-title>5'-UTR recruitment of the translation initiation factor eIF4GI or DAP5 drives cap-independent translation of a subset of human mRNAs</article-title><source>J. Biol. Chem.</source><volume>295</volume><year>2020</year><fpage>11693</fpage><lpage>11706</lpage><pub-id pub-id-type="pmid">32571876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.RA120.013678</pub-id><pub-id pub-id-type="pmcid">PMC7450097</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Plank</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Kieft</surname><given-names>J.S.</given-names></name></person-group><article-title>The structures of nonprotein-coding RNAs that drive internal ribosome entry site function</article-title><source>Wiley Interdiscip. Rev. RNA</source><volume>3</volume><year>2012</year><fpage>195</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">22215521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/wrna.1105</pub-id><pub-id pub-id-type="pmcid">PMC3973487</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Colussi</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Costantino</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Donohue</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Korostelev</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Jaafar</surname><given-names>Z.A.</given-names></name><etal/></person-group><article-title>Initiation of translation in bacteria by a structured eukaryotic IRES RNA</article-title><source>Nature</source><volume>519</volume><year>2015</year><fpage>110</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">25652826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature14219</pub-id><pub-id pub-id-type="pmcid">PMC4352134</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Pestova TV</surname><given-names>K.V.</given-names></name><name name-style="western"><surname>Lomakin</surname><given-names>I.B.</given-names></name><name name-style="western"><surname>Pilipenko</surname><given-names>E.V.</given-names></name><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name><name name-style="western"><surname>Agol</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Hellen</surname><given-names>C.U.</given-names></name></person-group><article-title>Molecular mechanisms of translation initiation in eukaryotes</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>98</volume><year>2001</year><fpage>7029</fpage><lpage>7036</lpage><pub-id pub-id-type="pmid">11416183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.111145798</pub-id><pub-id pub-id-type="pmcid">PMC34618</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Terenin</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Andreev</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Dmitriev</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name></person-group><article-title>A novel mechanism of eukaryotic translation initiation that is neither m<sup>7</sup>G-cap-, nor IRES-dependent</article-title><source>Nucleic Acids Res.</source><volume>41</volume><year>2013</year><fpage>1807</fpage><lpage>1816</lpage><pub-id pub-id-type="pmid">23268449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gks1282</pub-id><pub-id pub-id-type="pmcid">PMC3561988</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Bailey-Serres</surname><given-names>J.</given-names></name></person-group><article-title>Selective translation of cytoplasmic mRNAs in plants</article-title><source>Trends Plant Sci.</source><volume>4</volume><year>1999</year><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">10322548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1360-1385(99)01386-2</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Rong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Livingstone</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sukarieh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Petroulakis</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Crosby</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs</article-title><source>RNA</source><volume>14</volume><year>2008</year><fpage>1318</fpage><lpage>1327</lpage><pub-id pub-id-type="pmid">18515545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1261/rna.950608</pub-id><pub-id pub-id-type="pmcid">PMC2441981</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name name-style="western"><surname>Strudwick</surname><given-names>S.,B.K.</given-names></name></person-group><article-title>The emerging roles of translation factor eIF4E in the nucleus</article-title><source>Differ</source><volume>70</volume><year>2002</year><fpage>10</fpage><lpage>22</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1432-0436.2002.700102.x</pub-id><pub-id pub-id-type="pmid">11963652</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name name-style="western"><surname>Blais</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Addison</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Edge</surname><given-names>R.</given-names></name><name name-style="western"><surname>Falls</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wary</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress</article-title><source>Mol. Cell Biol.</source><volume>26</volume><year>2006</year><fpage>9517</fpage><lpage>9532</lpage><pub-id pub-id-type="pmid">17030613</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.01145-06</pub-id><pub-id pub-id-type="pmcid">PMC1698539</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name name-style="western"><surname>Mahe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rios-Fuller</surname><given-names>T.</given-names></name><name name-style="western"><surname>Katsara</surname><given-names>O.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>R.J.</given-names></name></person-group><article-title>Non-canonical mRNA translation initiation in cell stress and cancer</article-title><source>NAR Cancer</source><volume>6</volume><year>2024</year><object-id pub-id-type="publisher-id">zcae026</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/narcan/zcae026</pub-id><pub-id pub-id-type="pmcid">PMC11140632</pub-id><pub-id pub-id-type="pmid">38828390</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>4E-BP1, a multifactor regulated multifunctional protein</article-title><source>Cell Cycle</source><volume>15</volume><year>2016</year><fpage>781</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">26901143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15384101.2016.1151581</pub-id><pub-id pub-id-type="pmcid">PMC4845917</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name name-style="western"><surname>Gingras</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Raught</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gygi</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Niedzwiecka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Miron</surname><given-names>M.</given-names></name><name name-style="western"><surname>Burley</surname><given-names>S.K.</given-names></name><etal/></person-group><article-title>Hierarchical phosphorylation of the translation inhibitor 4E-BP1</article-title><source>Genes Dev.</source><volume>15</volume><year>2001</year><fpage>2852</fpage><lpage>2864</lpage><pub-id pub-id-type="pmid">11691836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.912401</pub-id><pub-id pub-id-type="pmcid">PMC312813</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tomoo</surname><given-names>K.</given-names></name><name name-style="western"><surname>Uchiyama</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ishida</surname><given-names>T.</given-names></name></person-group><article-title>Structural and thermodynamic behavior of eukaryotic initiation factor 4E in supramolecular formation with 4E-binding protein 1 and mRNA cap analogue, studied by spectroscopic methods</article-title><source>Chem. Pharma. Bull.</source><volume>49</volume><year>2001</year><fpage>1299</fpage><lpage>1303</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/cpb.49.1299</pub-id><pub-id pub-id-type="pmid">11605658</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name name-style="western"><surname>Siddiqui</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tempel</surname><given-names>W.</given-names></name><name name-style="western"><surname>Nedyalkova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Volpon</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wernimont</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Structural insights into the allosteric effects of 4E-BP1 on the eukaryotic translation initiation factor eIF4E</article-title><source>J. Mol. Biol.</source><volume>415</volume><year>2012</year><fpage>781</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">22178476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2011.12.002</pub-id><pub-id pub-id-type="pmcid">PMC3269305</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name name-style="western"><surname>Culjkovic-Kraljacic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Skrabanek</surname><given-names>L.</given-names></name><name name-style="western"><surname>Revuelta</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Gasiorek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cowling</surname><given-names>V.H.</given-names></name><name name-style="western"><surname>Cerchietti</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The eukaryotic translation initiation factor eIF4E elevates steady-state m(7)G capping of coding and noncoding transcripts</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>117</volume><year>2020</year><fpage>26773</fpage><lpage>26783</lpage><pub-id pub-id-type="pmid">33055213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2002360117</pub-id><pub-id pub-id-type="pmcid">PMC7604501</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name name-style="western"><surname>Coutinho de Oliveira</surname><given-names>L.</given-names></name><name name-style="western"><surname>Volpon</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rahardjo</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Osborne</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Culjkovic-Kraljacic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Trahan</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: implications for translation</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>116</volume><year>2019</year><fpage>24056</fpage><lpage>24065</lpage><pub-id pub-id-type="pmid">31712417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1904752116</pub-id><pub-id pub-id-type="pmcid">PMC6883836</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>R.</given-names></name><name name-style="western"><surname>McFarland</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kieft</surname><given-names>J.</given-names></name><name name-style="western"><surname>Niedzwiecka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jankowska-Anyszka</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Structural insights into parasite eIF4E binding specificity for m<sup>7</sup>G and m<sup>2,2,7</sup>G mRNA caps</article-title><source>J. Biol. Chem.</source><volume>284</volume><year>2009</year><fpage>31336</fpage><lpage>31349</lpage><pub-id pub-id-type="pmid">19710013</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M109.049858</pub-id><pub-id pub-id-type="pmcid">PMC2781531</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name name-style="western"><surname>Niedzwiecka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marcotrigiano</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stepinski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jankowska-Anyszka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wyslouch-Cieszynska</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dadlez</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins</article-title><source>J. Mol. Biol.</source><volume>319</volume><year>2002</year><fpage>615</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">12054859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0022-2836(02)00328-5</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name name-style="western"><surname>Osborne</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Volpon</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kornblatt</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Culjkovic-Kraljacic</surname><given-names>B.</given-names></name><name name-style="western"><surname>Baguet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Borden</surname><given-names>K.L.</given-names></name></person-group><article-title>eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>110</volume><year>2013</year><fpage>3877</fpage><lpage>3882</lpage><pub-id pub-id-type="pmid">23431134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1216862110</pub-id><pub-id pub-id-type="pmcid">PMC3593863</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>X.M.</given-names></name><name name-style="western"><surname>Blenis</surname><given-names>J.</given-names></name></person-group><article-title>Molecular mechanisms of mTOR-mediated translational control</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>10</volume><year>2009</year><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">19339977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm2672</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name name-style="western"><surname>Shull AY</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Awan</surname><given-names>F.T.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bollag</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Salman</surname><given-names>H.</given-names></name><etal/></person-group><article-title>RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia</article-title><source>Oncotarget</source><volume>6</volume><year>2015</year><fpage>14632</fpage><lpage>14645</lpage><pub-id pub-id-type="pmid">25999352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.4104</pub-id><pub-id pub-id-type="pmcid">PMC4546493</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name name-style="western"><surname>Andreev</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Dmitriev</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Terenin</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Prassolov</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Merrick</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name></person-group><article-title>Differential contribution of the m<sup>7</sup>G-cap to the 5' end-dependent translation initiation of mammalian mRNAs</article-title><source>Nucleic Acids Res.</source><volume>37</volume><year>2009</year><fpage>6135</fpage><lpage>6147</lpage><pub-id pub-id-type="pmid">19696074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkp665</pub-id><pub-id pub-id-type="pmcid">PMC2764426</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>B.</given-names></name><name name-style="western"><surname>Goss</surname><given-names>D.J.</given-names></name></person-group><article-title>Eukaryotic initiation factor (eIF) 4F binding to barley yellow dwarf virus (BYDV) 3'-untranslated region correlates with translation efficiency</article-title><source>J.Biol. Chem.</source><volume>289</volume><year>2014</year><fpage>4286</fpage><lpage>4294</lpage><pub-id pub-id-type="pmid">24379412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M113.530329</pub-id><pub-id pub-id-type="pmcid">PMC3924291</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name><name name-style="western"><surname>Dmitriev</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Terenin</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Andreev</surname><given-names>D.E.</given-names></name></person-group><article-title>Cap- and IRES-independent scanning mechanism of translation initiation as an alternative to the concept of cellular IRESs</article-title><source>Mol. Cells.</source><volume>30</volume><year>2010</year><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">21052925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10059-010-0149-1</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name name-style="western"><surname>Andreev</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Dmitriev</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Zinovkin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Terenin</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Shatsky</surname><given-names>I.N.</given-names></name></person-group><article-title>The 5' untranslated region of Apaf-1 mRNA directs translation under apoptosis conditions via a 5' end-dependent scanning mechanism</article-title><source>FEBS Lett.</source><volume>586</volume><year>2012</year><fpage>4139</fpage><lpage>4143</lpage><pub-id pub-id-type="pmid">23085065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.febslet.2012.10.010</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name name-style="western"><surname>Rousseau</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Pause</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth</article-title><source>Oncogene</source><volume>13</volume><year>1997</year><fpage>2415</fpage><lpage>2420</lpage><pub-id pub-id-type="pmid">8957083</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name name-style="western"><surname>Mothe-Satney</surname><given-names>I.,Y.D.</given-names></name><name name-style="western"><surname>Fadden</surname><given-names>P.</given-names></name><name name-style="western"><surname>Haystead</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>J.C.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression</article-title><source>Mol. Cell. Biol.</source><volume>20</volume><year>2000</year><fpage>3558</fpage><lpage>3567</lpage><pub-id pub-id-type="pmid">10779345</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.20.10.3558-3567.2000</pub-id><pub-id pub-id-type="pmcid">PMC85648</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name name-style="western"><surname>Thoreen</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Chantranupong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Keys</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Sabatini</surname><given-names>D.M.</given-names></name></person-group><article-title>A unifying model for mTORC1-mediated regulation of mRNA translation</article-title><source>Nature</source><volume>485</volume><year>2012</year><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">22552098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature11083</pub-id><pub-id pub-id-type="pmcid">PMC3347774</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name name-style="western"><surname>Constantinou</surname><given-names>C.</given-names></name><name name-style="western"><surname>Elia</surname><given-names>A.</given-names></name><name name-style="western"><surname>Clemens</surname><given-names>M.J.</given-names></name></person-group><article-title>Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1)</article-title><source>Biol. Cell</source><volume>100</volume><year>2008</year><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">18021075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BC20070121</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name name-style="western"><surname>Feoktistova</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tuvshintogs</surname><given-names>E.</given-names></name><name name-style="western"><surname>Do</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C.S.</given-names></name></person-group><article-title>Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>110</volume><year>2013</year><fpage>13339</fpage><lpage>13344</lpage><pub-id pub-id-type="pmid">23901100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1303781110</pub-id><pub-id pub-id-type="pmcid">PMC3746923</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name name-style="western"><surname>Avanzino</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C.S.</given-names></name></person-group><article-title>Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>114</volume><year>2017</year><fpage>9611</fpage><lpage>9616</lpage><pub-id pub-id-type="pmid">28827335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1704390114</pub-id><pub-id pub-id-type="pmcid">PMC5594656</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name name-style="western"><surname>Pause A</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Donz&#233;</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>J.C.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function</article-title><source>Nature</source><volume>371</volume><year>1994</year><fpage>762</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">7935836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/371762a0</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name name-style="western"><surname>Svitkin</surname><given-names>Y.V.</given-names></name><name name-style="western"><surname>Herdy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Costa-Mattioli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Raught</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation</article-title><source>Mol. Cell Biol.</source><volume>25</volume><year>2005</year><fpage>10556</fpage><lpage>10565</lpage><pub-id pub-id-type="pmid">16287867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.25.23.10556-10565.2005</pub-id><pub-id pub-id-type="pmcid">PMC1291233</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name name-style="western"><surname>Keiper</surname><given-names>B.D.</given-names></name><name name-style="western"><surname>Gan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Rhoads</surname><given-names>R.E.</given-names></name></person-group><article-title>Protein synthesis initiation factor 4G</article-title><source>Int. J. Biochem. Cell Biol.</source><volume>31</volume><year>1999</year><fpage>37</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10216942</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1357-2725(98)00130-7</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name name-style="western"><surname>Brito Querido</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sokabe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diaz-Lopez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gordiyenko</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Ramakrishnan</surname><given-names>V.</given-names></name></person-group><article-title>The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A</article-title><source>Nat. Struct. Mol. Biol.</source><volume>31</volume><year>2024</year><fpage>455</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">38287194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41594-023-01196-0</pub-id><pub-id pub-id-type="pmcid">PMC10948362</pub-id></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name name-style="western"><surname>Oberer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Marintchev</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>G.</given-names></name></person-group><article-title>Structural basis for the enhancement of eIF4A helicase activity by eIF4G</article-title><source>Genes Dev.</source><volume>19</volume><year>2005</year><fpage>2212</fpage><lpage>2223</lpage><pub-id pub-id-type="pmid">16166382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gad.1335305</pub-id><pub-id pub-id-type="pmcid">PMC1221891</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name name-style="western"><surname>Morino</surname><given-names>S.I.H.</given-names></name><name name-style="western"><surname>Svitkin</surname><given-names>Y.V.</given-names></name><name name-style="western"><surname>Pestova</surname><given-names>T.V.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Eukaryotic translation initiation factor 4E (eIF4E) binding site and the middle one-third of eIF4GI constitute the core domain for cap-dependent translation, and the C-terminal one-third functions as a modulatory region</article-title><source>Mol. Cell Biol.</source><volume>20</volume><year>2000</year><fpage>468</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">10611225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.20.2.468-477.2000</pub-id><pub-id pub-id-type="pmcid">PMC85104</pub-id></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name name-style="western"><surname>Sokabe</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>C.S.</given-names></name></person-group><article-title>A helicase-independent activity of eIF4A in promoting mRNA recruitment to the human ribosome</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>114</volume><year>2017</year><fpage>6304</fpage><lpage>6309</lpage><pub-id pub-id-type="pmid">28559306</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1620426114</pub-id><pub-id pub-id-type="pmcid">PMC5474785</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name name-style="western"><surname>Fletcher</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.-C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matsuo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name><etal/></person-group><article-title>4E-binding proteins inhibit the translation factor eIF4E without folded structure</article-title><source>Biochem</source><volume>37</volume><year>1998</year><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9453748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi972494r</pub-id></element-citation></ref><ref id="bib73"><label>73</label><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name name-style="western"><surname>Peter</surname><given-names>D.</given-names></name><name name-style="western"><surname>Igreja</surname><given-names>C.</given-names></name><name name-style="western"><surname>Weber</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wohlbold</surname><given-names>L.</given-names></name><name name-style="western"><surname>Weiler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ebertsch</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Molecular architecture of 4E-BP translational inhibitors bound to eIF4E</article-title><source>Mol. Cell.</source><volume>57</volume><year>2015</year><fpage>1074</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">25702871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2015.01.017</pub-id></element-citation></ref><ref id="bib74"><label>74</label><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bhardwaj</surname><given-names>U.</given-names></name><name name-style="western"><surname>Goss</surname><given-names>D.J.</given-names></name></person-group><article-title>Thermodynamically favorable interactions between eIF4E binding domain of eIF4GI with structured 5'-untranslated regions drive cap-independent translation of selected mRNAs</article-title><source>Biochem.</source><volume>62</volume><year>2023</year><fpage>1767</fpage><lpage>1775</lpage><pub-id pub-id-type="pmid">37132650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.biochem.3c00125</pub-id></element-citation></ref><ref id="bib75"><label>75</label><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name name-style="western"><surname>Modrak-Wojcik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gorka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Niedzwiecka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zdanowski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zuberek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Niedzwiecka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E-BP1, eIF4E, and the mRNA 5' cap</article-title><source>FEBS Lett.</source><volume>587</volume><year>2013</year><fpage>3928</fpage><lpage>3934</lpage><pub-id pub-id-type="pmid">24211447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.febslet.2013.10.043</pub-id></element-citation></ref><ref id="bib76"><label>76</label><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name name-style="western"><surname>Pelletier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA</article-title><source>Nature</source><volume>334</volume><year>1988</year><fpage>320</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">2839775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/334320a0</pub-id></element-citation></ref><ref id="bib77"><label>77</label><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Grosely</surname><given-names>R.</given-names></name><name name-style="western"><surname>Petrov</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Puglisi</surname><given-names>J.D.</given-names></name></person-group><article-title>Dynamics of IRES-mediated translation</article-title><source>Philos. Trans. R. Soc. Lond. B. Biol. Sci.</source><volume>372</volume><year>2017</year><object-id pub-id-type="publisher-id">20160177</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1098/rstb.2016.0177</pub-id><pub-id pub-id-type="pmcid">PMC5311923</pub-id><pub-id pub-id-type="pmid">28138065</pub-id></element-citation></ref><ref id="bib78"><label>78</label><element-citation publication-type="journal" id="sref78"><person-group person-group-type="author"><name name-style="western"><surname>Stein</surname><given-names>I.I.A.</given-names></name><name name-style="western"><surname>Einat</surname><given-names>P.</given-names></name><name name-style="western"><surname>Skaliter</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grossman</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Keshet</surname><given-names>E.</given-names></name></person-group><article-title>Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia</article-title><source>Mol. Cell Biol.</source><volume>18</volume><year>1998</year><fpage>3112</fpage><lpage>3119</lpage><pub-id pub-id-type="pmid">9584152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.18.6.3112</pub-id><pub-id pub-id-type="pmcid">PMC108893</pub-id></element-citation></ref><ref id="bib79"><label>79</label><element-citation publication-type="journal" id="sref79"><person-group person-group-type="author"><name name-style="western"><surname>Pestova TV</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Hellen</surname><given-names>C.U.</given-names></name></person-group><article-title>Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes</article-title><source>Mol. Cell Biol.</source><volume>16</volume><year>1996</year><fpage>6870</fpage><lpage>6878</lpage><pub-id pub-id-type="pmid">8943342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.16.12.6870</pub-id><pub-id pub-id-type="pmcid">PMC231690</pub-id></element-citation></ref><ref id="bib80"><label>80</label><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name name-style="western"><surname>Jaafar</surname><given-names>Z.A.</given-names></name><name name-style="western"><surname>Kieft</surname><given-names>J.S.</given-names></name></person-group><article-title>Viral RNA structure-based strategies to manipulate translation</article-title><source>Nat. Rev. Microbiol.</source><volume>17</volume><year>2019</year><fpage>110</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">30514982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41579-018-0117-x</pub-id><pub-id pub-id-type="pmcid">PMC6452865</pub-id></element-citation></ref><ref id="bib81"><label>81</label><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name name-style="western"><surname>Fraser</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Pain</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Morley</surname><given-names>S.J.</given-names></name></person-group><article-title>Cellular stress in Xenopus kidney cells enhances the phosphorylation of eukaryotic translation initiation factor eIF4E and the association of eIF4F with poly(A)-binding protein</article-title><source>Biochem. J.</source><volume>342</volume><year>1999</year><fpage>519</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">10477262</pub-id><pub-id pub-id-type="pmcid">PMC1220492</pub-id></element-citation></ref><ref id="bib82"><label>82</label><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name name-style="western"><surname>Ayuso</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Hernandez-Jimenez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Salinas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alcazar</surname><given-names>A.</given-names></name></person-group><article-title>New hierarchical phosphorylation pathway of the translational repressor eIF4E-binding protein 1 (4E-BP1) in ischemia-reperfusion stress</article-title><source>J. Biol. Chem.</source><volume>285</volume><year>2010</year><fpage>34355</fpage><lpage>34363</lpage><pub-id pub-id-type="pmid">20736160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M110.135103</pub-id><pub-id pub-id-type="pmcid">PMC2966049</pub-id></element-citation></ref><ref id="bib83"><label>83</label><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name name-style="western"><surname>Batool</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aashaq</surname><given-names>S.</given-names></name><name name-style="western"><surname>Andrabi</surname><given-names>K.I.</given-names></name></person-group><article-title>Eukaryotic initiation factor 4E (eIF4E): a recap of the cap-binding protein</article-title><source>J. Cell Biochem.</source><volume>120</volume><year>2019</year><fpage>14201</fpage><lpage>14212</lpage><pub-id pub-id-type="pmid">31074051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcb.28851</pub-id></element-citation></ref><ref id="bib84"><label>84</label><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name name-style="western"><surname>Beretta</surname><given-names>L.S.Y.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>Rapamycin stimulates viral protein synthesis and augments the shutoff of host protein synthesis upon picornavirus infection</article-title><source>J. Virol.</source><volume>70</volume><year>1996</year><fpage>8993</fpage><lpage>8996</lpage><pub-id pub-id-type="pmid">8971030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jvi.70.12.8993-8996.1996</pub-id><pub-id pub-id-type="pmcid">PMC190998</pub-id></element-citation></ref><ref id="bib85"><label>85</label><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name name-style="western"><surname>Ohayon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yitzhaky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hertzberg</surname><given-names>L.</given-names></name></person-group><article-title>Gene expression meta-analysis reveals the up-regulation of CREB1 and CREBBP in brodmann area 10 of patients with schizophrenia</article-title><source>Psychiatry Res.</source><volume>292</volume><year>2020</year><object-id pub-id-type="publisher-id">113311</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psychres.2020.113311</pub-id><pub-id pub-id-type="pmid">32712449</pub-id></element-citation></ref><ref id="bib86"><label>86</label><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name name-style="western"><surname>Shabani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sherafati Moghadam</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moghaddami</surname><given-names>K.</given-names></name></person-group><article-title>Effect of 8 weeks of endurance training on S6K1 and 4E-BP1 proteins content in the left ventricle of the heart of diabetic rats induced by streptozotocin and nicotinamide</article-title><source>J. Shahid Sadoughi Uni. Med. Sci.</source><volume>29</volume><year>2021</year><fpage>3658</fpage><lpage>3668</lpage></element-citation></ref><ref id="bib87"><label>87</label><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name name-style="western"><surname>Badura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Braunstein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zavadil</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>R.J.</given-names></name></person-group><article-title>DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>109</volume><year>2012</year><fpage>18767</fpage><lpage>18772</lpage><pub-id pub-id-type="pmid">23112151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1203853109</pub-id><pub-id pub-id-type="pmcid">PMC3503184</pub-id></element-citation></ref><ref id="bib88"><label>88</label><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name name-style="western"><surname>Pilipenko</surname><given-names>E.V.</given-names></name><name name-style="western"><surname>Pestova</surname><given-names>T.V.</given-names></name><name name-style="western"><surname>Kolupaeva</surname><given-names>V.G.</given-names></name><name name-style="western"><surname>Khitrina</surname><given-names>E.V.</given-names></name><name name-style="western"><surname>Poperechnaya</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Agol</surname><given-names>V.I.</given-names></name><name name-style="western"><surname>Hellen</surname><given-names>C.U.</given-names></name></person-group><article-title>A cell cycle-dependent protein serves as a template-specific translation initiation factor</article-title><source>Genes Dev.</source><volume>14</volume><year>2000</year><fpage>2028</fpage><lpage>2045</lpage><pub-id pub-id-type="pmid">10950867</pub-id><pub-id pub-id-type="pmcid">PMC316860</pub-id></element-citation></ref><ref id="bib89"><label>89</label><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name name-style="western"><surname>Kaminski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>R.J.</given-names></name></person-group><article-title>The polypyrimidine tract binding protein (PTB) requirement for internal initiation of translation of cardiovirus RNAs is conditional rather than absolute</article-title><source>RNA</source><volume>4</volume><year>1998</year><fpage>626</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">9622122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/s1355838298971898</pub-id><pub-id pub-id-type="pmcid">PMC1369645</pub-id></element-citation></ref><ref id="bib90"><label>90</label><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name name-style="western"><surname>De Gregorio</surname><given-names>E.P.T.</given-names></name><name name-style="western"><surname>Hentze</surname><given-names>M.W.</given-names></name></person-group><article-title>Translation driven by an eIF4G core domain in vivo</article-title><source>EMBO J.</source><volume>18</volume><year>1999</year><fpage>4865</fpage><lpage>4874</lpage><pub-id pub-id-type="pmid">10469664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/18.17.4865</pub-id><pub-id pub-id-type="pmcid">PMC1171558</pub-id></element-citation></ref><ref id="bib91"><label>91</label><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name name-style="western"><surname>Clarkson</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>W.V.</given-names></name><name name-style="western"><surname>Doudna</surname><given-names>J.A.</given-names></name></person-group><article-title>Functional overlap between eIF4G isoforms in Saccharomyces cerevisiae</article-title><source>PLoS One</source><volume>5</volume><year>2010</year><object-id pub-id-type="publisher-id">e9114</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0009114</pub-id><pub-id pub-id-type="pmcid">PMC2817733</pub-id><pub-id pub-id-type="pmid">20161741</pub-id></element-citation></ref><ref id="bib92"><label>92</label><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Warringer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sunnerhagen</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hinnebusch</surname><given-names>A.G.</given-names></name></person-group><article-title>Depletion of eIF4G from yeast cells narrows the range of translational efficiencies genome-wide</article-title><source>BMC Genomics</source><volume>12</volume><year>2011</year><fpage>68</fpage><pub-id pub-id-type="pmid">21269496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2164-12-68</pub-id><pub-id pub-id-type="pmcid">PMC3042410</pub-id></element-citation></ref><ref id="bib93"><label>93</label><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name name-style="western"><surname>De Benedetti</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rhoads</surname><given-names>R.E.</given-names></name></person-group><article-title>Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>87</volume><year>1990</year><fpage>8212</fpage><lpage>8216</lpage><pub-id pub-id-type="pmid">2122455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.87.21.8212</pub-id><pub-id pub-id-type="pmcid">PMC54925</pub-id></element-citation></ref><ref id="bib94"><label>94</label><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name name-style="western"><surname>Koromilas</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Lazaris-Karatzas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sonenberg</surname><given-names>N.</given-names></name></person-group><article-title>mRNAs containing extensive secondary structure in their 5&#8242; non-coding region translate efficiently in cells over-expressing initiation factor eIF4E</article-title><source>EMBO J.</source><volume>11</volume><year>1992</year><fpage>4153</fpage><lpage>4158</lpage><pub-id pub-id-type="pmid">1396596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1992.tb05508.x</pub-id><pub-id pub-id-type="pmcid">PMC556925</pub-id></element-citation></ref><ref id="bib95"><label>95</label><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name name-style="western"><surname>Enriquez-Flores</surname><given-names>S.</given-names></name><name name-style="western"><surname>De la Mora-De la Mora</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Flores-Lopez</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>N.</given-names></name><name name-style="western"><surname>Fernandez-Lainez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hernandez-Alcantara</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant</article-title><source>Appl. Microbiol. Biotechnol.</source><volume>106</volume><year>2022</year><fpage>1475</fpage><lpage>1492</lpage><pub-id pub-id-type="pmid">35092453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-022-11786-5</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supporting information</title><p id="p0210">
<supplementary-material content-type="local-data" id="mmc1" position="float" orientation="portrait"><caption><title>Supplementary Material</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.docx" position="float" orientation="portrait"/></supplementary-material>
</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0195">We thank Izza Nawaz for initiating this project. Dr Dustin Wheeler and Dr Paul Powell for assistance with instruments.</p><sec id="sec6"><title>Author contributions</title><p id="p0200">B. S. and D. J. G. writing&#8211;review &amp; editing; B. S. and M. M validation; B. S. and M. M methodology; B. S. and M. M investigation; B. S., M. M., and D. J. G. formal analysis; M. M. and D. J. G. conceptualization; D. J. G. supervision; D. J. G. resources; D. J. G. project administration; D. J. G. funding acquisition.</p></sec><sec id="sec7"><title>Funding and additional information</title><p id="p0205">The research reported in this publication was supported by the <funding-source id="gs1">National Science Foundation</funding-source>
<award-id award-type="grant" rid="gs1">MCB-2317112</award-id> (to D. J. G.).</p></sec></ack></back></article></pmc-articleset>